6-K 1 a6151x.htm 1ST QUARTER RESULTS a6151x
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
 
FORM 6-K
 
 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
April 27, 2023
 
Barclays PLC
(Name of Registrant)
 
1 Churchill Place
London E14 5HP
England
(Address of Principal Executive Office)
 
Indicate by check mark whether the registrant files or will file annual reports
under cover of Form 20-F or Form 40-F.
 
Form 20-F x Form 40-F
 
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
 
Yes No x
 
If "Yes" is marked, indicate below the file number assigned to the registrant
in connection with Rule 12g3-2(b):
 
This Report on Form 6-K is filed by Barclays PLC.
 
This Report comprises:
 
Information given to The London Stock Exchange and furnished pursuant to
General Instruction B to the General Instructions to Form 6-K.
 
 


 
 
 
SIGNATURES
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
BARCLAYS PLC
 
(Registrant)
 
 
 
Date: April 27, 2023
 
 
 
By: /s/ Garth Wright
--------------------------------
 
Garth Wright
 
Assistant Secretary
 
 
 
 
 
 
Barclays PLC
 
 
 
Q1 2023 Results Announcement
 
 
 
31 March 2023
 
 
 
Notes
 
The terms Barclays and Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the three months ended 31 March 2023 to the corresponding three months of 2022 and balance sheet analysis as at 31 March 2023 with comparatives relating to 31 December 2022 and 31 March 2022. The abbreviations ‘£m’ and ‘£bn’ represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations ‘$m’ and ‘$bn’ represent millions and thousands of millions of US Dollars respectively; and the abbreviations ‘€m’ and ‘€bn’ represent millions and thousands of millions of Euros respectively.
 
There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.
 
Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS) are explained in the results glossary, which can be accessed at home.barclays/investor-relations.
 
The information in this announcement, which was approved by the Board of Directors on 26 April 2023, does not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2022, which contained an unmodified audit report under Section 495 of the Companies Act 2006 (which did not make any statements under Section 498 of the Companies Act 2006) will be delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.
 
These results will be furnished on Form 6-K with the US Securities and Exchange Commission (SEC) as soon as practicable following their publication. Once furnished with the SEC, a copy of the Form 6-K will be available from the SEC’s website at www.sec.gov.

Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal road-shows and other ad hoc meetings. Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these results and other matters relating to the Group.
 
 
Non-IFRS performance measures
 
Barclays’ management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays’ management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 38 to 43 for further information and calculations of non-IFRS performance measures included throughout this document, and the most directly comparable IFRS measures.
 
 
Forward-looking statements
 
This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. Forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’, ‘target’, ‘projected’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by directors, officers and employees of the Group (including during management presentations) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group’s future financial position, income levels, costs, assets and liabilities, impairment charges, provisions, capital, leverage and other regulatory ratios, capital distributions (including dividend policy and share buybacks), return on tangible equity, projected levels of growth in banking and financial markets, industry trends, any commitments and targets (including environmental, social and governance (ESG) commitments and targets), business strategy, plans and objectives for future operations and other statements that are not historical or current facts. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as at the date on which they are made. Forward-looking statements may be affected by a number of factors, including, without limitation: changes in legislation, regulation and the interpretation thereof, changes in IFRS and other accounting standards, including practices with regard to the interpretation and application thereof and emerging and developing ESG reporting standards; the outcome of current and future legal proceedings and regulatory investigations; the policies and actions of governmental and regulatory authorities; the Group’s ability along with governments and other stakeholders to measure, manage and mitigate the impacts of climate change effectively; environmental, social and geopolitical risks and incidents and similar events beyond the Group’s control; the impact of competition; capital, leverage and other regulatory rules applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions, including inflation; volatility in credit and capital markets; market related risks such as changes in interest rates and foreign exchange rates; higher or lower asset valuations; changes in credit ratings of any entity within the Group or any securities issued by it; changes in counterparty risk; changes in consumer behaviour; the direct and indirect consequences of the Russia-Ukraine war on European and global macroeconomic conditions, political stability and financial markets; direct and indirect impacts of the coronavirus (COVID-19) pandemic; instability as a result of the UK’s exit from the European Union (EU), the effects of the EU-UK Trade and Cooperation Agreement and any disruption that may subsequently result in the UK and globally; the risk of cyber-attacks, information or security breaches or technology failures on the Group’s reputation, business or operations; the Group’s ability to access funding; and the success of acquisitions, disposals and other strategic transactions. A number of these factors are beyond the Group’s control. As a result, the Group’s actual financial position, results, financial and non-financial metrics or performance measures or its ability to meet commitments and targets may differ materially from the statements or guidance set forth in the Group’s forward-looking statements. Additional risks and factors which may impact the Group’s future financial condition and performance are identified in Barclays PLC’s filings with the SEC (including, without limitation, Barclays PLC’s Annual Report on Form 20-F for the financial year ended 31 December 2022), which are available on the SEC’s website at www.sec.gov.
 
 
Subject to Barclays PLC’s obligations under the applicable laws and regulations of any relevant jurisdiction (including, without limitation, the UK and the US) in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
 
 
Performance Highlights
 
Barclays delivered a return on tangible equity (RoTE) of 15.0% and remains on track to deliver its 2023 targets, with all performance metrics in line with or ahead of guidance at Q123
 
 
C. S. Venkatakrishnan, Group Chief Executive, commented
"This is a strong first quarter with Group income up 11% to £7.2bn and profit before tax up 16% to £2.6bn, generating a Group RoTE of 15.0% and earnings per share (EPS) of 11.3p. All three businesses have performed well with high quality income growth and double-digit returns. The momentum across the Group allows us to maintain a robust capital position, deliver attractive returns to shareholders, and support our customers and clients through an uncertain economic environment."
 
 
Key financial metrics:
 
 
 
Income
Cost: income ratio
LLR
Profit before tax
Attributable profit
RoTE
EPS
LCR
Loan: deposit ratio
TNAV per share
CET1 ratio
Q123
£7.2bn
57%
52bps
£2.6bn
£1.8bn
15.0%
11.3p
163%
73%
301p
13.6%
 
 
Q123 Performance highlights:
 
 
Group attributable profit was £1.8bn and RoTE was 15.0%, with all operating divisions delivering double-digit returns
Group income was £7.2bn, up 11% year-on-year, with diverse sources of growth across the Group as well as the benefit from USD appreciation:
 
Barclays UK income increased 19% primarily driven by net interest income growth from higher rates and continued structural hedge income momentum, delivering a net interest margin (NIM) of 3.18%
 
Corporate and Investment Bank (CIB) income increased 1% to £4.0bn, representing a record Q1 income performance1. Drivers included a strong performance in Transaction banking and Global Markets, against a record prior year comparative, with lower Investment Banking income due to a reduced industry fee pool2
 
Consumer, Cards and Payments (CC&P) income increased 47% from growth in US cards balances, including the Gap portfolio acquisition3, and growth in client assets and liabilities in the Private Bank, as well as the higher rate environment
Group operating expenses were £4.1bn, in line with prior year, including the non-repeat of certain litigation and conduct items. Group operating expenses excluding litigation and conduct charges increased to £4.1bn (Q122: £3.6bn) reflecting the impact of business growth, inflation and USD appreciation. The Group delivered positive statutory cost: income jaws and a cost: income ratio of 57%
Credit impairment charges were £0.5bn, with a loan loss rate (LLR) of 52bps, within the guided range of 50-60bps, reflecting higher US cards balances and the continuing normalisation anticipated in US cards delinquencies. Coverage ratios remain strong
Common Equity Tier 1 (CET1) ratio of 13.6% (December 2022: 13.9%) reflected the expected reduction of an aggregate c.40bps of capital impacts in Q123 including the £0.5bn buyback announced at FY22, and seasonally higher Risk Weighted Assets (RWAs) in the Global Markets business, which supported the strong Q1 income performance
Tangible net asset value (TNAV) per share of 301p, increased 6p since December 2022
Liquidity coverage ratio (LCR) of 163% (December 2022: 165%) and Net Stable Funding Ratio (NSFR) of 139% (December 2022: 137%), well above regulatory minimum requirements
Loan: deposit ratio was maintained at 73% (December 2022: 73%). The Group maintains a diverse and stable deposit franchise including across wholesale and consumer as well as across different geographies
 
 
1
On a comparable basis, period covering 2014-Q123. Pre 2014 data was not restated following re-segmentation in 2016.
2
Data source: Dealogic for the period covering 1 January to 31 March 2023.
3
The Gap portfolio refers to the Gap Inc. US credit card portfolio.
 
 
Group Targets and Outlook:
 
Returns: targeting RoTE of greater than 10% in 2023, consistent with our medium-term target
Income: diversified income streams continue to position the Group well for the current economic and market environment including higher interest rates. In 2023, Barclays UK NIM is expected to be greater than 3.20%1
Costs: targeting a cost: income ratio percentage in the low 60s in 2023, investing for growth whilst progressing towards the Group’s medium-term target of below 60%
Impairment: expect an LLR of 50-60bps in 2023, based on the current macroeconomic outlook
Capital: expect to operate within the CET1 ratio medium-term target range of 13-14%
Capital returns: capital distribution policy incorporates a progressive ordinary dividend, supplemented with share buybacks as appropriate
 
 
1
Assumes the UK bank rate peaks at 4.25% in 2023.
 
 
Barclays Group results
for the three months ended
 
31.03.23
31.03.22
 
 
£m
£m
% Change
Barclays UK
1,961
1,649
19
Corporate and Investment Bank
3,976
3,938
1
Consumer, Cards and Payments
1,306
886
47
Barclays International
5,282
4,824
9
Head Office
(6)
23
 
Total income
7,237
6,496
11
Operating costs
(4,111)
(3,588)
(15)
Litigation and conduct
1
(523)
 
Total operating expenses
(4,110)
(4,111)
Other net expenses
(5)
(10)
50
Profit before impairment
3,122
2,375
31
Credit impairment charges
(524)
(141)
 
Profit before tax
2,598
2,234
16
Tax charge
(561)
(614)
9
Profit after tax
2,037
1,620
26
Non-controlling interests
(8)
(1)
 
Other equity instrument holders
(246)
(215)
(14)
Attributable profit
1,783
1,404
27
 
 
 
 
Performance measures
 
 
 
Return on average tangible shareholders' equity
15.0%
11.5%
 
Average tangible shareholders' equity (£bn)
47.6
48.8
 
Cost: income ratio
57%
63%
 
Loan loss rate (bps)
52
15
 
Basic earnings per share
11.3p
8.4p
 
Basic weighted average number of shares (m)
15,770
16,682
(5)
Period end number of shares (m)
15,701
16,762
(6)
 
 
 
As at 31.03.23
As at 31.12.22
As at 31.03.22
Balance sheet and capital management1
£bn
£bn
£bn
Loans and advances at amortised cost
403.5
398.8
371.7
Loans and advances at amortised cost impairment coverage ratio
1.4%
1.4%
1.5%
Total assets
1,539.1
1,513.7
1,496.1
Deposits at amortised cost
555.7
545.8
546.5
Tangible net asset value per share
301p
295p
294p
Common equity tier 1 ratio
13.6%
13.9%
13.8%
Common equity tier 1 capital
46.0
46.9
45.3
Risk weighted assets
338.4
336.5
328.8
UK leverage ratio
5.1%
5.3%
5.0%
UK leverage exposure
1,168.9
1,130.0
1,123.5
Average UK leverage ratio
4.8%
4.8%
4.8%
Average UK leverage exposure
1,251.3
1,281.0
1,179.4
 
 
 
 
Funding and liquidity
 
 
 
Group liquidity pool (£bn)
333.0
318.0
319.8
Liquidity coverage ratio
163%
165%
159%
Net stable funding ratio2
139%
137%
 
Loan: deposit ratio
73%
73%
68%
 
 
1
Refer to pages 29 to 34 for further information on how capital, RWAs and leverage are calculated.
2
Represents average of the last four spot quarter end positions.
 
 
Group Finance Director’s Review
 
 
Group performance
 
 
Barclays delivered a profit before tax of £2,598m (Q122: £2,234m), RoTE of 15.0% (Q122: 11.5%) and EPS of 11.3p (Q122: 8.4p)
The Group has a diverse income profile across businesses and geographies including a significant presence in the US. The appreciation of average USD against GBP positively impacted income and profits and adversely impacted credit impairment charges and total operating expenses
Group income increased 11% to £7,237m primarily from the higher interest rate environment and continued structural hedge income momentum benefiting Barclays UK, Transaction banking and the Private Bank, the benefit of higher balances in US cards, and growth in client assets and liabilities in the Private Bank
Group operating expenses were stable at £4,110m (Q122: £4,111m)
 
Group operating expenses excluding litigation and conduct charges increased to £4,111m (Q122: £3,588m) reflecting the impact of business growth and inflation
 
The prior year litigation and conduct charges of £523m included charges relating to the Over-issuance of Securities in the US (Over-issuance of Securities1) and customer remediation costs relating to a legacy loan portfolio
Credit impairment charges were £524m (Q122: £141m) reflecting higher US cards balances, including the Gap portfolio acquisition in Q222, and the continuing normalisation anticipated in US cards delinquencies. Total coverage ratio remains strong at 1.4% (December 2022: 1.4%)
The effective tax rate (ETR) was 21.6% (Q122: 27.5%). The prior year included the tax charge recognised for the re-measurement of the Group’s UK deferred tax assets as a result of the UK banking surcharge rate being reduced from 8% to 3%
Attributable profit was £1,783m (Q122: £1,404m)
Total assets increased to £1,539.1bn (December 2022: £1,513.7bn) driven by increased trading and client activity within Global Markets and the acquisition of Kensington Mortgage Company (KMC), partially offset by strengthening of GBP against USD since December 2022. The Group liquidity pool was further strengthened by growth in deposits and wholesale funding
TNAV per share increased to 301p (December 2022: 295p) as EPS of 11.3p and other reserve movements were partially offset by the 2022 full year dividend paid on 31 March 2023
 
 
Barclays UK
 
 
Barclays UK delivered a RoTE of 20.0% supported by higher interest rates and the continued investment in our transformation into a next-generation, digitised consumer bank.
Profit before tax increased 27% to £754m with a RoTE of 20.0% (Q122: 15.6%)
Total income increased 19% to £1,961m. Net interest income increased 21% to £1,618m with a NIM of 3.18% (Q122: 2.62%), continuing to build as higher interest rates and associated structural hedge benefit outweighed mortgage margin pressure. Net fee, commission and other income increased 11% to £343m partially driven by transactional income in Business Banking and UK cards
 
Personal Banking income increased 23% to £1,253m, driven by higher interest rates, partially offset by mortgage margin compression
 
Barclaycard Consumer UK income decreased 11% to £247m as higher customer spend volumes were more than offset by lower interest earning lending balances following repayments and ongoing prudent risk management
 
Business Banking income increased 31% to £461m driven by higher interest rates alongside improved transaction based revenues, partially offset by lower government scheme lending as repayments continue
Total operating expenses increased 9% to £1,094m from the impact of inflation with ongoing efficiency savings reinvested in digitisation to support further improvements to the cost: income ratio over time
Credit impairment charges were £113m (Q122: £48m), reflecting limited observed deterioration. UK cards 30 and 90 day arrears remained below pre-pandemic levels at 0.9% (Q122: 1.0%) and 0.2% (Q122: 0.3%) respectively2. The UK cards total coverage ratio was 7.7% (December 2022: 7.6%)
Loans and advances to customers at amortised cost increased 2% to £208.2bn primarily reflecting the acquisition of KMC
Customer deposits at amortised cost decreased 1% to £254.3bn. Increases in savings product balances were more than offset by reduced current account and business banking deposits, reflecting broader market trends. The loan: deposit ratio increased to 90% (December 2022: 87%)
RWAs increased to £74.6bn (December 2022: £73.1bn) including £0.8bn related to the acquisition of KMC
 
 
1
Denotes the Over-issuance of Securities under Barclays Bank PLC's (BBPLC) US shelf registration statements on Form F-3 filed with the SEC in 2018 and 2019.
2
As at 31 December 2019, UK cards 30 and 90 days arrears were 1.7% and 0.8% respectively.
 
 
Barclays International
 
 
Barclays International delivered a RoTE of 14.5%. CIB continued to support clients through a period of market volatility, with performance reflecting the benefits of income diversification and continued investment in sustainable growth. CC&P performance reflects continued investment in the business resulting in balance growth and increased income, partially offset by higher impairment charges.
Profit before tax increased 13% to £1,928m with a RoTE of 14.5% (Q122: 14.8%), reflecting a RoTE of 15.2% (Q122: 17.1%) in CIB and 10.5% (Q122: (1.5)%) in CC&P
Barclays International has a diverse income profile across businesses and geographies including a significant presence in the US. The appreciation of average USD against GBP positively impacted income and profits, and adversely impacted credit impairment charges and total operating expenses
Total income increased to £5,282m (Q122: £4,824m)
 
CIB income of £3,976m (Q122: £3,938m) represented the best Q1 on a comparable basis1
 
 
Global Markets income of £2,492m decreased 8% against a record prior year comparative. FICC income increased 9% to £1,788m, driven by a strong performance in credit. Equities income decreased 33% to £704m driven by a decline in derivatives income reflecting less volatile equity market conditions relative to prior year
 
 
 
Investment Banking fees decreased 7% to £603m due to the reduced fee pool2, partially offset by a strong performance in advisory representing the best Q1 performance1
 
 
 
Within Corporate, Transaction banking income increased 68% to £786m representing the best Q1 performance1, driven by improved margins, in the higher rate environment, in deposits. Corporate lending income decreased 24% to £95m mainly driven by costs of higher credit protection
 
 
CC&P income increased 47% to £1,306m
 
 
International Cards and Consumer Bank income increased 67% to £900m reflecting higher cards balances and improved margins, including the Gap portfolio acquisition in Q222
 
 
 
Private Bank income increased 21% to £258m, reflecting client balance growth and improved margins
 
 
 
Payments income increased 10% to £148m driven by merchant acquiring turnover growth
 
Total operating expenses decreased 2% to £2,953m and increased 18% to £2,956m excluding litigation and conduct, reflecting continued investment in the business
 
CIB total operating expenses decreased 2% to £2,199m. Operating expenses excluding litigation and conduct charges increased 15% to £2,202m driven by continued investment in talent and technology, and the impact of appreciation of average USD and inflation
 
CC&P total operating expenses decreased 3% to £754m. Operating expenses excluding litigation and conduct charges increased 29% to £754m, driven by higher investment spend to support growth, mainly in marketing and partnership costs, including the Gap portfolio acquisition, and the impact of appreciation of average USD and inflation
Credit impairment charges were £404m (Q122: £101m) reflecting higher balances and the continuing normalisation anticipated in US cards delinquencies
 
CIB credit impairment charges of £33m (Q122: £33m net release) were driven by single name charges partially offset by the benefit of credit protection
 
CC&P credit impairment charges increased to £371m (Q122: £134m), reflecting higher US cards balances, including the Gap portfolio, and the continuing normalisation anticipated in delinquencies. US cards 30 and 90 day arrears were 2.3% (Q122: 1.6%) and 1.2% (Q122: 0.8%) respectively. The US cards total coverage ratio was 8.9% (December 2022: 8.1%)
RWAs increased to £255.1bn (December 2022: £254.8bn) mainly supporting increased client and trading activity within Global Markets, partially offset by strengthening of GBP against USD since December 2022
 
 
Head Office
 
 
Loss before tax was £84m (Q122: £73m)
Total income was an expense of £6m (Q122: £23m income) with hedge accounting gains offset by treasury items. The prior year included a one-off gain of £86m from the sale and leaseback of UK data centres
Total operating expenses were £63m (Q122: £86m)
RWAs were £8.8bn (December 2022: £8.6bn)
 
 
1
On a comparable basis, period covering 2014-Q123. Pre 2014 data was not restated following re-segmentation in 2016.
2
Data source: Dealogic for the period covering 1 January to 31 March 2023.
 
 
Capital distributions
 
 
Barclays paid the 2022 full year dividend of 5.0p on 31 March 2023 and completed the £0.5bn share buyback programme announced at FY22 results on 14 April 2023
Barclays is committed to maintaining a balance between a strong capital position, delivering total cash returns to shareholders and investment in the business. Barclays pays a progressive ordinary dividend, taking into account these objectives and the earnings outlook of the Group. The Board will also continue to supplement the ordinary dividend as appropriate, including with share buybacks
 
 
Group capital and leverage
 
 
The CET1 ratio decreased by c.30bps to 13.6% (December 2022: 13.9%) as RWAs increased by £1.9bn to £338.4bn and CET1 capital decreased by £0.9bn to £46.0bn:
 
c.50bps increase from attributable profit generated in the quarter
 
c.40bps aggregate decrease from expected capital impacts in Q123, including the £0.5bn share buyback announced at FY22 results, the impact of regulatory change on 1 January 2023 relating to IFRS 9 transitional relief, and the impact of the KMC acquisition
 
c.20bps decrease as a result of a £5.2bn increase in RWAs primarily driven by increased client and trading activity within Global Markets
 
c.20bps decrease primarily due to increased regulatory capital deductions and an accrual for the FY23 dividend
 
A £4.0bn decrease in RWAs as a result of foreign exchange movements was broadly offset by a £0.5bn decrease in the currency translation reserve
The UK leverage ratio decreased to 5.1% (December 2022: 5.3%) primarily due to a £38.9bn increase in leverage exposure and a £0.4bn decrease in Tier 1 capital. The UK leverage exposure increased to £1,168.9bn (December 2022: £1,130.0bn) largely due to an increase in securities financing transactions (SFT) client and trading activity within Global Markets
 
 
Group funding and liquidity
 
 
The liquidity and funding position remains robust and strengthened further in Q123. The liquidity pool increased to £333.0bn (December 2022: £318.0bn) driven by growth in deposits and increased wholesale funding. The composition of the liquidity pool is conservative, with 82% held in cash and deposits with central banks and the remainder primarily held in high quality government bonds, materially held at fair value or hedged
The strength of the funding and liquidity position is supported by a diverse and stable deposit franchise. Total deposits increased to £555.7bn (December 2022: £545.8bn)
The liquidity coverage ratio remained significantly above the 100% regulatory requirement at 163% (December 2022: 165%), equivalent to a surplus of £122.0bn (December 2022: £116.4bn)
Net Stable Funding Ratio (average of last four quarter ends) was 139% (December 2022: 137%), which represents a £166.7bn (December 2022: £155.6bn) surplus above 100% regulatory requirement
Wholesale funding outstanding, excluding repurchase agreements, was £192.2bn (December 2022: £184.0bn)
The Group issued £2.8bn equivalent of minimum requirement for own funds and eligible liabilities (MREL) instruments from Barclays PLC (the Parent company) in Q123. The Group has a strong MREL position with a ratio of 32.7%, which is in excess of the regulatory requirement of 29% plus a confidential, institution specific, Prudential Regulation Authority (PRA) buffer
 
 
Other matters
 
 
KMC acquisition: further to the announcement in Q222, on 1 March 2023 Barclays completed the acquisition of UK specialist mortgage lender KMC, including a portfolio of mortgages totalling £2.2bn with an RWA impact of £0.8bn. The transaction broadens Barclays' existing mortgage product range by adding a leading UK specialist residential mortgage lender with an established track record in the UK market, further enhancing its product capabilities consistent with Barclays’ strategic priority to deliver next-generation, digitised consumer financial services
 
 
Anna Cross, Group Finance Director
 
Results by Business
 
Barclays UK
Three months ended
 
31.03.23
31.03.22
 
Income statement information
£m
£m
% Change
Net interest income
1,618
1,339
21
Net fee, commission and other income
343
310
11
Total income
1,961
1,649
19
Operating costs
(1,092)
(998)
(9)
Litigation and conduct
(2)
(9)
78
Total operating expenses
(1,094)
(1,007)
(9)
Other net income
 
Profit before impairment
867
642
35
Credit impairment charges
(113)
(48)
 
Profit before tax
754
594
27
Attributable profit
515
396
30
 
 
 
 
Performance measures
 
 
 
Return on average allocated tangible equity
20.0%
15.6%
 
Average allocated tangible equity (£bn)
10.3
10.1
 
Cost: income ratio
56%
61%
 
Loan loss rate (bps)
20
9
 
Net interest margin
3.18%
2.62%
 
 
 
 
 
 
As at 31.03.23
As at 31.12.22
As at 31.03.22
Balance sheet information
£bn
£bn
£bn
Loans and advances to customers at amortised cost
208.2
205.1
207.3
Total assets
308.6
313.2
317.2
Customer deposits at amortised cost
254.3
258.0
260.3
Loan: deposit ratio
90%
87%
85%
Risk weighted assets
74.6
73.1
72.7
Period end allocated tangible equity
10.3
10.1
10.1
 
 
 
 
 
 
Analysis of Barclays UK
Three months ended
31.03.23
31.03.22
 
Analysis of total income
£m
£m
% Change
Personal Banking
1,253
1,022
23
Barclaycard Consumer UK
247
276
(11)
Business Banking
461
351
31
Total income
1,961
1,649
19
 
 
 
 
Analysis of credit impairment charges
 
 
 
Personal Banking
(28)
21
 
Barclaycard Consumer UK
(83)
(44)
(89)
Business Banking
(2)
(25)
92
Total credit impairment charges
(113)
(48)
 
 
 
 
 
 
As at 31.03.23
As at 31.12.22
As at 31.03.22
Analysis of loans and advances to customers at amortised cost
£bn
£bn
£bn
Personal Banking
173.6
169.7
166.5
Barclaycard Consumer UK
9.0
9.2
8.4
Business Banking
25.6
26.2
32.4
Total loans and advances to customers at amortised cost
208.2
205.1
207.3
 
 
 
 
Analysis of customer deposits at amortised cost
 
 
 
Personal Banking
194.3
195.6
196.6
Barclaycard Consumer UK
Business Banking
60.0
62.4
63.7
Total customer deposits at amortised cost
254.3
258.0
260.3
 
 
 
 
Barclays International
Three months ended
 
31.03.23
31.03.22
 
Income statement information
£m
£m
% Change
Net interest income
1,354
936
45
Net trading income
2,419
2,446
(1)
Net fee, commission and other income
1,509
1,442
5
Total income
5,282
4,824
9
Operating costs
(2,956)
(2,505)
(18)
Litigation and conduct
3
(513)
 
Total operating expenses
(2,953)
(3,018)
2
Other net income
3
8
(63)
Profit before impairment
2,332
1,814
29
Credit impairment charges
(404)
(101)
 
Profit before tax
1,928
1,713
13
Attributable profit
1,348
1,300
4
 
 
 
 
Performance measures
 
 
 
Return on average allocated tangible equity
14.5%
14.8%
 
Average allocated tangible equity (£bn)
37.1
35.1
 
Cost: income ratio
56%
63%
 
Loan loss rate (bps)
94
28
 
Net interest margin
5.87%
4.15%
 
 
 
 
 
 
As at 31.03.23
As at 31.12.22
As at 31.03.22
Balance sheet information
£bn
£bn
£bn
Loans and advances to customers at amortised cost
131.0
133.7
113.9
Loans and advances to banks at amortised cost
9.8
8.7
10.2
Debt securities at amortised cost
30.8
27.2
20.7
Loans and advances at amortised cost
171.6
169.6
144.8
Trading portfolio assets
137.7
133.8
134.1
Derivative financial instrument assets
256.6
301.7
288.8
Financial assets at fair value through the income statement
245.0
210.5
203.8
Cash collateral and settlement balances
125.5
107.7
132.0
Other assets
275.0
258.0
255.5
Total assets
1,211.4
1,181.3
1,159.0
Deposits at amortised cost
301.6
287.6
286.1
Derivative financial instrument liabilities
246.7
288.9
277.2
Loan: deposit ratio
57%
59%
51%
Risk weighted assets
255.1
254.8
245.1
Period end allocated tangible equity
36.8
36.8
35.6
 
 
 
 
 
 
Analysis of Barclays International
 
 
Corporate and Investment Bank
Three months ended
 
31.03.23
31.03.22
 
Income statement information
£m
£m
% Change
Net interest income
465
385
21
Net trading income
2,437
2,450
(1)
Net fee, commission and other income
1,074
1,103
(3)
Total income
3,976
3,938
1
Operating costs
(2,202)
(1,921)
(15)
Litigation and conduct
3
(318)
 
Total operating expenses
(2,199)
(2,239)
2
Other net income
 
Profit before impairment
1,777
1,699
5
Credit impairment (charges)/releases
(33)
33
 
Profit before tax
1,744
1,732
1
Attributable profit
1,209
1,316
(8)
 
 
 
 
Performance measures
 
 
 
Return on average allocated tangible equity
15.2%
17.1%
 
Average allocated tangible equity (£bn)
31.8
30.8
 
Cost: income ratio
55%
57%
 
Loan loss rate (bps)
10
(12)
 
 
 
 
 
 
As at 31.03.23
As at 31.12.22
As at 31.03.22
Balance sheet information
£bn
£bn
£bn
Loans and advances to customers at amortised cost
89.2
90.5
79.5
Loans and advances to banks at amortised cost
9.2
8.1
9.4
Debt securities at amortised cost
30.7
27.2
20.7
Loans and advances at amortised cost
129.1
125.8
109.6
Trading portfolio assets
137.6
133.7
134.0
Derivative financial instrument assets
256.5
301.6
288.7
Financial assets at fair value through the income statement
244.9
210.5
203.8
Cash collateral and settlement balances
124.7
106.9
131.2
Other assets
230.3
222.6
222.5
Total assets
1,123.1
1,101.1
1,089.8
Deposits at amortised cost
221.0
205.8
214.7
Derivative financial instrument liabilities
246.7
288.9
277.1
Risk weighted assets
216.8
215.9
213.5
 
 
 
 
 
Three months ended
 
31.03.23
31.03.22
 
Analysis of total income
£m
£m
% Change
FICC
1,788
1,644
9
Equities
704
1,052
(33)
Global Markets
2,492
2,696
(8)
Advisory
212
185
15
Equity capital markets
50
47
6
Debt capital markets
341
416
(18)
Investment Banking fees
603
648
(7)
Corporate lending
95
125
(24)
Transaction banking
786
469
68
Corporate
881
594
48
Total income
3,976
3,938
1
 
 
Analysis of Barclays International
 
 
Consumer, Cards and Payments
Three months ended
 
31.03.23
31.03.22
 
Income statement information
£m
£m
% Change
Net interest income
889
551
61
Net fee, commission, trading and other income
417
335
24
Total income
1,306
886
47
Operating costs
(754)
(584)
(29)
Litigation and conduct
(195)
 
Total operating expenses
(754)
(779)
3
Other net income
3
8
(63)
Profit before impairment
555
115
 
Credit impairment charges
(371)
(134)
 
Profit/(loss) before tax
184
(19)
 
Attributable profit/(loss)
139
(16)
 
 
 
 
 
Performance measures
 
 
 
Return on average allocated tangible equity
10.5%
(1.5)%
 
Average allocated tangible equity (£bn)
5.3
4.3
 
Cost: income ratio
58%
88%
 
Loan loss rate (bps)
332
145
 
 
 
 
 
 
As at 31.03.23
As at 31.12.22
As at 31.03.22
Balance sheet information
£bn
£bn
£bn
Loans and advances to customers at amortised cost
41.8
43.2
34.4
Total assets
88.3
80.2
69.2
Deposits at amortised cost
80.6
81.8
71.4
Risk weighted assets
38.2
38.9
31.6
 
 
 
 
 
Three months ended
 
31.03.23
31.03.22
 
Analysis of total income
£m
£m
% Change
International Cards and Consumer Bank
900
538
67
Private Bank
258
214
21
Payments
148
134
10
Total income
1,306
886
47
 
 
Head Office
Three months ended
 
31.03.23
31.03.22
 
Income statement information
£m
£m
% Change
Net interest income
81
66
23
Net fee, commission and other income
(87)
(43)
 
Total income
(6)
23
 
Operating costs
(63)
(85)
26
Litigation and conduct
(1)
 
Total operating expenses
(63)
(86)
27
Other net expenses
(8)
(18)
56
Loss before impairment
(77)
(81)
5
Credit impairment (charges)/releases
(7)
8
 
Loss before tax
(84)
(73)
(15)
Attributable loss
(80)
(292)
73
 
 
 
 
Performance measures
 
 
 
Average allocated tangible equity (£bn)
0.2
3.6
 
 
 
 
 
 
As at 31.03.23
As at 31.12.22
As at 31.03.22
Balance sheet information
£bn
£bn
£bn
Total assets
19.1
19.2
19.9
Risk weighted assets
8.8
8.6
11.0
Period end allocated tangible equity
0.2
(0.2)
3.6
 
 
Quarterly Results Summary
 
 
Barclays Group
 
 
 
 
 
 
 
 
 
 
 
Q123
 
Q422
Q322
Q222
Q122
 
Q4211
Q3211
Q2211
Income statement information
£m
 
£m
£m
£m
£m
 
£m
£m
£m
Net interest income
3,053
 
2,741
3,068
2,422
2,341
 
2,230
1,940
2,052
Net fee, commission and other income
4,184
 
3,060
2,883
4,286
4,155
 
2,930
3,525
3,363
Total income
7,237
 
5,801
5,951
6,708
6,496
 
5,160
5,465
5,415
Operating costs
(4,111)
 
(3,748)
(3,939)
(3,682)
(3,588)
 
(3,514)
(3,446)
(3,587)
UK bank levy
 
(176)
 
(170)
Litigation and conduct
1
 
(79)
339
(1,334)
(523)
 
(92)
(129)
(143)
Total operating expenses
(4,110)
 
(4,003)
(3,600)
(5,016)
(4,111)
 
(3,776)
(3,575)
(3,730)
Other net (expenses)/income
(5)
 
10
(1)
7
(10)
 
13
94
21
Profit before impairment
3,122
 
1,808
2,350
1,699
2,375
 
1,397
1,984
1,706
Credit impairment (charges)/releases
(524)
 
(498)
(381)
(200)
(141)
 
31
(120)
797
Profit before tax
2,598
 
1,310
1,969
1,499
2,234
 
1,428
1,864
2,503
Tax (charge)/credit
(561)
 
33
(249)
(209)
(614)
 
(104)
(292)
(246)
Profit after tax
2,037
 
1,343
1,720
1,290
1,620
 
1,324
1,572
2,257
Non-controlling interests
(8)
 
(22)
(2)
(20)
(1)
 
(27)
(1)
(15)
Other equity instrument holders
(246)
 
(285)
(206)
(199)
(215)
 
(218)
(197)
(194)
Attributable profit
1,783
 
1,036
1,512
1,071
1,404
 
1,079
1,374
2,048
 
 
 
 
 
 
 
 
 
 
 
Performance measures
 
 
 
 
 
 
 
 
 
 
Return on average tangible shareholders' equity
15.0%
 
8.9%
12.5%
8.7%
11.5%
 
9.0%
11.4%
17.6%
Average tangible shareholders' equity (£bn)
47.6
 
46.7
48.6
49.0
48.8
 
48.0
48.3
46.5
Cost: income ratio
57%
 
69%
60%
75%
63%
 
73%
65%
69%
Loan loss rate (bps)
52
 
49
36
20
15
 
(3)
13
(90)
Basic earnings per share
11.3p
 
6.5p
9.4p
6.4p
8.4p
 
6.4p
8.0p
11.9p
Basic weighted average number of shares (m)
15,770
 
15,828
16,148
16,684
16,682
 
16,985
17,062
17,140
Period end number of shares (m)
15,701
 
15,871
15,888
16,531
16,762
 
16,752
16,851
16,998
 
 
 
 
 
 
 
 
 
 
 
Balance sheet and capital management2
£bn
 
£bn
£bn
£bn
£bn
 
£bn
£bn
£bn
Loans and advances to customers at amortised cost
343.6
 
343.3
346.3
337.2
325.8
 
319.9
313.5
309.2
Loans and advances to banks at amortised cost
11.0
 
10.0
12.5
12.5
11.4
 
9.7
10.6
11.0
Debt securities at amortised cost
48.9
 
45.5
54.8
46.1
34.5
 
31.8
28.9
28.3
Loans and advances at amortised cost
403.5
 
398.8
413.7
395.8
371.7
 
361.5
353.0
348.5
Loans and advances at amortised cost impairment coverage ratio
1.4%
 
1.4%
1.4%
1.4%
1.5%
 
1.6%
1.7%
1.8%
Total assets
1,539.1
 
1,513.7
1,726.9
1,589.2
1,496.1
 
1,384.3
1,406.5
1,376.3
Deposits at amortised cost
555.7
 
545.8
574.4
568.7
546.5
 
519.4
510.2
500.9
Tangible net asset value per share
301p
 
295p
286p
297p
294p
 
291p
286p
280p
Common equity tier 1 ratio
13.6%
 
13.9%
13.8%
13.6%
13.8%
 
15.1%
15.3%
15.0%
Common equity tier 1 capital
46.0
 
46.9
48.6
46.7
45.3
 
47.3
47.2
46.2
Risk weighted assets
338.4
 
336.5
350.8
344.5
328.8
 
314.1
307.7
307.4
UK leverage ratio
5.1%
 
5.3%
5.0%
5.1%
5.0%
 
5.2%
5.1%
5.0%
UK leverage exposure
1,168.9
 
1,130.0
1,232.1
1,151.2
1,123.5
 
1,137.9
1,162.7
1,154.9
Average UK leverage ratio
4.8%
 
4.8%
4.8%
4.7%
4.8%
 
4.9%
4.9%
4.8%
Average UK leverage exposure
1,251.3
 
1,281.0
1,259.6
1,233.5
1,179.4
 
1,229.0
1,201.1
1,192.7
 
 
 
 
 
 
 
 
 
 
 
Funding and liquidity
 
 
 
 
 
 
 
 
 
 
Group liquidity pool (£bn)
333.0
 
318.0
325.8
342.5
319.8
 
291.0
292.8
290.8
Liquidity coverage ratio
163%
 
165%
151%
156%
159%
 
168%
161%
162%
Net stable funding ratio3
139%
 
137%
 
 
 
 
 
 
 
Loan: deposit ratio
73%
 
73%
72%
70%
68%
 
70%
69%
70%
 
 
1
The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities.
2
Refer to pages 29 to 34 for further information on how capital, RWAs and leverage are calculated.
3
Represents average of the last four spot quarter end positions.
 
Quarterly Results by Business
 
 
Barclays UK
 
 
 
 
 
 
 
 
 
 
 
Q123
 
Q422
Q322
Q222
Q122
 
Q421
Q321
Q221
Income statement information
£m
 
£m
£m
£m
£m
 
£m
£m
£m
Net interest income
1,618
 
1,600
1,561
1,393
1,339
 
1,313
1,303
1,305
Net fee, commission and other income
343
 
370
355
331
310
 
386
335
318
Total income
1,961
 
1,970
1,916
1,724
1,649
 
1,699
1,638
1,623
Operating costs
(1,092)
 
(1,108)
(1,069)
(1,085)
(998)
 
(1,202)
(1,041)
(1,078)
UK bank levy
 
(26)
 
(36)
Litigation and conduct
(2)
 
(13)
(3)
(16)
(9)
 
(5)
(10)
(19)
Total operating expenses
(1,094)
 
(1,147)
(1,072)
(1,101)
(1,007)
 
(1,243)
(1,051)
(1,097)
Other net income/(expenses)
 
1
(1)
 
(1)
1
Profit before impairment
867
 
824
843
623
642
 
455
588
526
Credit impairment (charges)/releases
(113)
 
(157)
(81)
(48)
 
59
(137)
520
Profit before tax
754
 
667
762
623
594
 
514
451
1,046
Attributable profit
515
 
474
549
458
396
 
420
317
721
 
 
 
 
 
 
 
 
 
 
 
Balance sheet information
£bn
 
£bn
£bn
£bn
£bn
 
£bn
£bn
£bn
Loans and advances to customers at amortised cost
208.2
 
205.1
205.1
205.9
207.3
 
208.8
208.6
207.8
Total assets
308.6
 
313.2
316.8
318.8
317.2
 
321.2
312.1
311.2
Customer deposits at amortised cost
254.3
 
258.0
261.0
261.5
260.3
 
260.6
256.8
255.5
Loan: deposit ratio
90%
 
87%
86%
85%
85%
 
85%
86%
87%
Risk weighted assets
74.6
 
73.1
73.2
72.2
72.7
 
72.3
73.2
72.2
Period end allocated tangible equity
10.3
 
10.1
10.1
9.9
10.1
 
10.0
10.0
9.9
 
 
 
 
 
 
 
 
 
 
 
Performance measures
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
20.0%
 
18.7%
22.1%
18.4%
15.6%
 
16.8%
12.7%
29.1%
Average allocated tangible equity (£bn)
10.3
 
10.2
9.9
10.0
10.1
 
10.0
10.0
9.9
Cost: income ratio
56%
 
58%
56%
64%
61%
 
73%
64%
68%
Loan loss rate (bps)
20
 
27
14
9
 
(10)
24
(93)
Net interest margin
3.18%
 
3.10%
3.01%
2.71%
2.62%
 
2.49%
2.49%
2.55%
 
 
Analysis of Barclays UK
Q123
 
Q422
Q322
Q222
Q122
 
Q421
Q321
Q221
Analysis of total income
£m
 
£m
£m
£m
£m
 
£m
£m
£m
Personal Banking
1,253
 
1,229
1,212
1,077
1,022
 
983
990
987
Barclaycard Consumer UK
247
 
269
283
265
276
 
352
293
290
Business Banking
461
 
472
421
382
351
 
364
355
346
Total income
1,961
 
1,970
1,916
1,724
1,649
 
1,699
1,638
1,623
 
 
 
 
 
 
 
 
 
 
 
Analysis of credit impairment (charges)/releases
 
 
 
 
 
 
 
 
 
 
Personal Banking
(28)
 
(120)
(26)
(42)
21
 
8
(30)
72
Barclaycard Consumer UK
(83)
 
(12)
2
84
(44)
 
114
(108)
434
Business Banking
(2)
 
(25)
(57)
(42)
(25)
 
(63)
1
14
Total credit impairment (charges)/releases
(113)
 
(157)
(81)
(48)
 
59
(137)
520
 
 
 
 
 
 
 
 
 
 
 
Analysis of loans and advances to customers at amortised cost
£bn
 
£bn
£bn
£bn
£bn
 
£bn
£bn
£bn
Personal Banking
173.6
 
169.7
168.7
167.1
166.5
 
165.4
164.6
162.4
Barclaycard Consumer UK
9.0
 
9.2
9.0
8.8
8.4
 
8.7
8.6
8.8
Business Banking
25.6
 
26.2
27.4
30.0
32.4
 
34.7
35.4
36.6
Total loans and advances to customers at amortised cost
208.2
 
205.1
205.1
205.9
207.3
 
208.8
208.6
207.8
 
 
 
 
 
 
 
 
 
 
 
Analysis of customer deposits at amortised cost
 
 
 
 
 
 
 
 
 
 
Personal Banking
194.3
 
195.6
197.3
197.0
196.6
 
196.4
193.3
191.0
Barclaycard Consumer UK
 
 
0.1
Business Banking
60.0
 
62.4
63.7
64.5
63.7
 
64.2
63.5
64.4
Total customer deposits at amortised cost
254.3
 
258.0
261.0
261.5
260.3
 
260.6
256.8
255.5
 
 
Barclays International
 
 
 
 
 
 
 
 
 
 
 
Q123
 
Q422
Q322
Q222
Q122
 
Q4211
Q3211
Q2211
Income statement information
£m
 
£m
£m
£m
£m
 
£m
£m
£m
Net interest income
1,354
 
1,465
1,497
1,029
936
 
955
749
811
Net trading income
2,419
 
1,169
1,328
2,766
2,446
 
789
1,515
1,455
Net fee, commission and other income
1,509
 
1,228
1,240
1,321
1,442
 
1,766
1,673
1,553
Total income
5,282
 
3,862
4,065
5,116
4,824
 
3,510
3,937
3,819
Operating costs
(2,956)
 
(2,543)
(2,776)
(2,537)
(2,505)
 
(2,160)
(2,310)
(2,168)
UK bank levy
 
(133)
 
(134)
Litigation and conduct
3
 
(67)
396
(1,319)
(513)
 
(84)
(100)
(140)
Total operating expenses
(2,953)
 
(2,743)
(2,380)
(3,856)
(3,018)
 
(2,378)
(2,410)
(2,308)
Other net income
3
 
5
10
5
8
 
3
15
13
Profit before impairment
2,332
 
1,124
1,695
1,265
1,814
 
1,135
1,542
1,524
Credit impairment (charges)/releases
(404)
 
(328)
(295)
(209)
(101)
 
(23)
18
271
Profit before tax
1,928
 
796
1,400
1,056
1,713
 
1,112
1,560
1,795
Attributable profit
1,348
 
625
1,136
783
1,300
 
818
1,191
1,207
 
 
 
 
 
 
 
 
 
 
 
Balance sheet information
£bn
 
£bn
£bn
£bn
£bn
 
£bn
£bn
£bn
Loans and advances to customers at amortised cost
131.0
 
133.7
137.0
126.7
113.9
 
106.4
99.9
96.3
Loans and advances to banks at amortised cost
9.8
 
8.7
11.0
11.3
10.2
 
8.4
9.4
9.9
Debt securities at amortised cost
30.8
 
27.2
36.2
29.3
20.7
 
19.0
16.6
15.7
Loans and advances at amortised cost
171.6
 
169.6
184.2
167.3
144.8
 
133.8
125.9
121.9
Trading portfolio assets
137.7
 
133.8
126.3
126.9
134.1
 
146.9
144.8
147.1
Derivative financial instrument assets
256.6
 
301.7
415.7
343.5
288.8
 
261.5
257.0
255.4
Financial assets at fair value through the income statement
245.0
 
210.5
244.7
209.3
203.8
 
188.2
200.5
190.4
Cash collateral and settlement balances
125.5
 
107.7
163.3
128.5
132.0
 
88.1
115.9
108.5
Other assets
275.0
 
258.0
257.2
275.1
255.5
 
225.6
231.8
223.5
Total assets
1,211.4
 
1,181.3
1,391.4
1,250.6
1,159.0
 
1,044.1
1,075.9
1,046.8
Deposits at amortised cost
301.6
 
287.6
313.2
307.4
286.1
 
258.8
253.3
245.4
Derivative financial instrument liabilities
246.7
 
288.9
394.2
321.2
277.2
 
256.4
252.3
246.9
Loan: deposit ratio
57%
 
59%
59%
54%
51%
 
52%
50%
50%
Risk weighted assets
255.1
 
254.8
269.3
263.8
245.1
 
230.9
222.7
223.2
Period end allocated tangible equity
36.8
 
36.8
38.8
38.0
35.6
 
33.2
31.8
31.8
 
 
 
 
 
 
 
 
 
 
 
Performance measures
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
14.5%
 
6.4%
11.6%
8.4%
14.8%
 
9.9%
14.9%
14.9%
Average allocated tangible equity (£bn)
37.1
 
38.9
39.1
37.3
35.1
 
32.9
31.8
32.4
Cost: income ratio
56%
 
71%
59%
75%
63%
 
68%
61%
60%
Loan loss rate (bps)
94
 
75
62
49
28
 
7
(6)
(87)
Net interest margin
5.87%
 
5.71%
5.58%
4.52%
4.15%
 
4.14%
4.02%
3.96%
 
 
1
The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities.
 
 
Analysis of Barclays International
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate and Investment Bank
Q123
 
Q422
Q322
Q222
Q122
 
Q4211
Q3211
Q2211
Income statement information
£m
 
£m
£m
£m
£m
 
£m
£m
£m
Net interest income
465
 
548
606
410
385
 
432
279
370
Net trading income
2,437
 
1,201
1,344
2,738
2,450
 
774
1,467
1,494
Net fee, commission and other income
1,074
 
827
871
885
1,103
 
1,426
1,383
1,115
Total income
3,976
 
2,576
2,821
4,033
3,938
 
2,632
3,129
2,979
Operating costs
(2,202)
 
(1,796)
(2,043)
(1,870)
(1,921)
 
(1,562)
(1,747)
(1,623)
UK bank levy
 
(126)
 
(128)
Litigation and conduct
3
 
(55)
498
(1,314)
(318)
 
(59)
(99)
(78)
Total operating expenses
(2,199)
 
(1,977)
(1,545)
(3,184)
(2,239)
 
(1,749)
(1,846)
(1,701)
Other net income
 
2
 
1
Profit before impairment
1,777
 
601
1,276
849
1,699
 
884
1,283
1,278
Credit impairment (charges)/releases
(33)
 
(41)
(46)
(65)
33
 
73
128
229
Profit before tax
1,744
 
560
1,230
784
1,732
 
957
1,411
1,507
Attributable profit
1,209
 
454
1,015
579
1,316
 
695
1,085
989
 
 
 
 
 
 
 
 
 
 
 
Balance sheet information
£bn
 
£bn
£bn
£bn
£bn
 
£bn
£bn
£bn
Loans and advances to customers at amortised cost
89.2
 
90.5
93.6
86.5
79.5
 
73.4
68.3
66.3
Loans and advances to banks at amortised cost
9.2
 
8.1
10.2
10.0
9.4
 
7.6
8.9
9.0
Debt securities at amortised cost
30.7
 
27.2
36.2
29.3
20.7
 
19.0
16.6
15.7
Loans and advances at amortised cost
129.1
 
125.8
140.0
125.8
109.6
 
100.0
93.8
91.0
Trading portfolio assets
137.6
 
133.7
126.1
126.7
134.0
 
146.7
144.7
147.0
Derivative financial instruments assets
256.5
 
301.6
415.5
343.4
288.7
 
261.5
256.9
255.3
Financial assets at fair value through the income statement
244.9
 
210.5
244.6
209.2
203.8
 
188.1
200.4
190.3
Cash collateral and settlement balances
124.7
 
106.9
162.6
127.7
131.2
 
87.2
115.1
107.7
Other assets
230.3
 
222.6
220.6
237.2
222.5
 
195.8
200.4
192.5
Total assets
1,123.1
 
1,101.1
1,309.4
1,170.0
1,089.8
 
979.3
1,011.3
983.8
Deposits at amortised cost
221.0
 
205.8
229.5
229.5
214.7
 
189.4
185.8
178.2
Derivative financial instrument liabilities
246.7
 
288.9
394.2
321.2
277.1
 
256.4
252.2
246.8
Risk weighted assets
216.8
 
215.9
230.6
227.6
213.5
 
200.7
192.5
194.3
 
 
 
 
 
 
 
 
 
 
 
Performance measures
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
15.2%
 
5.4%
11.9%
7.1%
17.1%
 
9.7%
15.6%
14.0%
Average allocated tangible equity (£bn)
31.8
 
33.7
34.0
32.7
30.8
 
28.7
27.8
28.4
Cost: income ratio
55%
 
77%
55%
79%
57%
 
66%
59%
57%
Loan loss rate (bps)
10
 
13
13
20
(12)
 
(29)
(54)
(100)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analysis of total income
£m
 
£m
£m
£m
£m
 
£m
£m
£m
FICC
1,788
 
976
1,546
1,529
1,644
 
546
803
895
Equities
704
 
440
246
1,411
1,052
 
501
757
777
Global Markets
2,492
 
1,416
1,792
2,940
2,696
 
1,047
1,560
1,672
Advisory
212
 
197
150
236
185
 
287
253
218
Equity capital markets
50
 
40
42
37
47
 
158
186
226
Debt capital markets
341
 
243
341
281
416
 
511
532
429
Investment Banking fees
603
 
480
533
554
648
 
956
971
873
Corporate lending
95
 
(128)
(181)
(47)
125
 
176
168
38
Transaction banking
786
 
808
677
586
469
 
453
430
396
Corporate
881
 
680
496
539
594
 
629
598
434
Total income
3,976
 
2,576
2,821
4,033
3,938
 
2,632
3,129
2,979
 
 
1
The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities.
 
 
Analysis of Barclays International
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consumer, Cards and Payments
Q123
 
Q422
Q322
Q222
Q122
 
Q421
Q321
Q221
Income statement information
£m
 
£m
£m
£m
£m
 
£m
£m
£m
Net interest income
889
 
918
891
619
551
 
522
471
441
Net fee, commission, trading and other income
417
 
368
353
464
335
 
356
337
399
Total income
1,306
 
1,286
1,244
1,083
886
 
878
808
840
Operating costs
(754)
 
(747)
(733)
(667)
(584)
 
(598)
(563)
(545)
UK bank levy
 
(7)
 
(6)
Litigation and conduct
 
(12)
(102)
(5)
(195)
 
(25)
(1)
(62)
Total operating expenses
(754)
 
(766)
(835)
(672)
(779)
 
(629)
(564)
(607)
Other net income
3
 
3
10
5
8
 
2
15
13
Profit before impairment
555
 
523
419
416
115
 
251
259
246
Credit impairment (charges)/releases
(371)
 
(287)
(249)
(144)
(134)
 
(96)
(110)
42
Profit/(loss) before tax
184
 
236
170
272
(19)
 
155
149
288
Attributable profit/(loss)
139
 
171
121
204
(16)
 
123
106
218
 
 
 
 
 
 
 
 
 
 
 
Balance sheet information
£bn
 
£bn
£bn
£bn
£bn
 
£bn
£bn
£bn
Loans and advances to customers at amortised cost
41.8
 
43.2
43.4
40.2
34.4
 
33.0
31.6
30.0
Total assets
88.3
 
80.2
82.0
80.6
69.2
 
64.8
64.6
63.0
Deposits at amortised cost
80.6
 
81.8
83.7
77.9
71.4
 
69.4
67.5
67.2
Risk weighted assets
38.2
 
38.9
38.7
36.2
31.6
 
30.2
30.2
29.0
 
 
 
 
 
 
 
 
 
 
 
Performance measures
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
10.5%
 
13.0%
9.5%
17.8%
(1.5)%
 
11.7%
10.5%
21.8%
Average allocated tangible equity (£bn)
5.3
 
5.2
5.1
4.6
4.3
 
4.2
4.0
4.0
Cost: income ratio
58%
 
60%
67%
62%
88%
 
72%
70%
72%
Loan loss rate (bps)
332
 
245
211
132
145
 
105
127
(49)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analysis of total income
£m
 
£m
£m
£m
£m
 
£m
£m
£m
International Cards and Consumer Bank
900
 
860
824
691
538
 
552
490
517
Private Bank
258
 
285
270
245
214
 
200
188
214
Payments
148
 
141
150
147
134
 
126
130
109
Total income
1,306
 
1,286
1,244
1,083
886
 
878
808
840
 
 
Head Office
 
 
 
 
 
 
 
 
 
 
 
Q123
 
Q422
Q322
Q222
Q122
 
Q421
Q321
Q221
Income statement information
£m
 
£m
£m
£m
£m
 
£m
£m
£m
Net interest income
81
 
(324)
10
66
 
(38)
(112)
(64)
Net fee, commission and other income
(87)
 
293
(40)
(132)
(43)
 
(11)
2
37
Total income
(6)
 
(31)
(30)
(132)
23
 
(49)
(110)
(27)
Operating costs
(63)
 
(97)
(94)
(60)
(85)
 
(152)
(95)
(341)
UK bank levy
 
(17)
 
Litigation and conduct
 
1
(54)
1
(1)
 
(3)
(19)
16
Total operating expenses
(63)
 
(113)
(148)
(59)
(86)
 
(155)
(114)
(325)
Other net (expenses)/income
(8)
 
4
(10)
2
(18)
 
11
78
8
Loss before impairment
(77)
 
(140)
(188)
(189)
(81)
 
(193)
(146)
(344)
Credit impairment (charges)/releases
(7)
 
(13)
(5)
9
8
 
(5)
(1)
6
Loss before tax
(84)
 
(153)
(193)
(180)
(73)
 
(198)
(147)
(338)
Attributable (loss)/profit
(80)
 
(63)
(173)
(170)
(292)
 
(159)
(134)
120
 
 
 
 
 
 
 
 
 
 
 
Balance sheet information
£bn
 
£bn
£bn
£bn
£bn
 
£bn
£bn
£bn
Total assets
19.1
 
19.2
18.7
19.8
19.9
 
19.0
18.5
18.3
Risk weighted assets1
8.8
 
8.6
8.2
8.6
11.0
 
11.0
11.8
12.0
Period end allocated tangible equity1
0.2
 
(0.2)
(3.5)
1.1
3.6
 
5.5
6.3
5.9
 
 
 
 
 
 
 
 
 
 
 
Performance measures1
 
 
 
 
 
 
 
 
 
 
Average allocated tangible equity (£bn)
0.2
 
(2.4)
(0.4)
1.7
3.6
 
5.1
6.5
4.2
 
 
1
The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities.
 
 
 
Performance Management
 
 
Margins and balances
 
Three months ended 31.03.23
Three months ended 31.03.22
 
Net interest income
Average customer assets
Net interest margin
Net interest income
Average customer assets
Net interest margin
 
£m
£m
%
£m
£m
%
Barclays UK
1,618
206,241
3.18
1,339
207,607
2.62
Corporate and Investment Bank1
551
56,612
3.95
316
50,798
2.52
Consumer, Cards and Payments
889
42,840
8.42
551
34,040
6.56
Barclays International1
1,440
99,452
5.87
867
84,838
4.15
Total Barclays UK and Barclays International
3,058
305,693
4.06
2,206
292,445
3.06
Other2
(5)
 
 
135
 
 
Total Barclays Group
3,053
 
 
2,341
 
 
 
 
1
CIB and Barclays International margins include the lending related investment bank business.
2
Other includes Head Office and the non-lending related investment bank businesses not included in Barclays International margins.
 
 
The Barclays UK and Barclays International NIM has increased 100bps from 3.06% in Q122 to 4.06% in Q123, driven by the higher interest rate environment and continued structural hedge income momentum across the Group, higher balances in CC&P including the Gap portfolio acquisition, partially offset by Mortgage margin compression and lower interest-earning lending in UK Cards.
 
The Group’s combined product and equity structural hedge notional amount as at 31 March 2023 was £260bn (31 March 2022: £238bn), with an average duration of close to 2.5 years (2022: average duration close to 3 years). Gross structural hedge contributions of £773m (Q122: £378m) and net structural hedge contributions of £(1,709)m (Q122: £141m) are included in Group net interest income. Gross structural hedge contributions represent the absolute level of interest earned from the fixed receipts on swaps in the structural hedge, while the net structural hedge contributions represent the net interest earned on the difference between the structural hedge rate and prevailing floating rates.
 
 
Quarterly analysis for Barclays UK and Barclays International
Net interest income
 
Average customer assets
Net interest margin
Three months ended 31.12.22
£m
£m
%
Barclays UK
1,600
204,941
3.10
Corporate and Investment Bank
556
59,146
3.73
Consumer, Cards and Payments
918
43,319
8.40
Barclays International1
1,474
102,465
5.71
Total Barclays UK and Barclays International
3,074
307,406
3.97
 
 
 
 
Three months ended 30.09.22
 
 
 
Barclays UK
1,561
205,881
3.01
Corporate and Investment Bank
529
58,891
3.56
Consumer, Cards and Payments
891
42,019
8.41
Barclays International1
1,420
100,910
5.58
Total Barclays UK and Barclays International
2,981
306,791
3.85
 
 
 
 
Three months ended 30.06.22
 
 
 
Barclays UK
1,393
205,834
2.71
Corporate and Investment Bank
397
55,181
2.88
Consumer, Cards and Payments
619
37,190
6.68
Barclays International1
1,016
92,371
4.41
Total Barclays UK and Barclays International
2,409
298,205
3.24
 
 
 
 
Three months ended 31.03.22
 
 
 
Barclays UK
1,339
207,607
2.62
Corporate and Investment Bank
316
50,798
2.52
Consumer, Cards and Payments
551
34,040
6.56
Barclays International1
867
84,838
4.15
Total Barclays UK and Barclays International
2,206
292,445
3.06
 
 
1
CIB and Barclays International margins include the lending related investment bank business.
 
 
Credit Risk
 
Loans and advances at amortised cost by stage
 
The table below presents a stage allocation and business segment analysis of loans and advances at amortised cost by gross exposure, impairment allowance, impairment charge and coverage ratio as at 31 March 2023. Also included are stage allocation of off-balance sheet loan commitments and financial guarantee contracts by gross exposure, impairment allowance and coverage as at 31 March 2023.
 
Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to gross loans and advances to the extent allowance does not exceed the drawn exposure and any excess is reported on the liabilities side of the balance sheet as a provision. For wholesale portfolios, impairment allowance on undrawn exposure is reported on the liability side of the balance sheet as a provision.
 
 
 
 
Gross exposure
 
Impairment allowance
Net exposure
 
Stage 1
Stage 2
Stage 3
Total
 
Stage 1
Stage 2
Stage 3
Total
As at 31.03.23
£m
£m
£m
£m
 
£m
£m
£m
£m
£m
Barclays UK
163,313
25,272
2,453
191,038
 
272
729
489
1,490
189,548
Barclays International
32,359
4,615
1,855
38,829
 
373
1,243
1,065
2,681
36,148
Head Office
3,435
281
577
4,293
 
3
26
324
353
3,940
Total Barclays Group retail
199,107
30,168
4,885
234,160
 
648
1,998
1,878
4,524
229,636
Barclays UK
34,603
3,086
790
38,479
 
74
110
91
275
38,204
Barclays International
122,198
12,971
1,232
136,401
 
279
240
401
920
135,481
Head Office
227
17
244
 
17
17
227
Total Barclays Group wholesale1
157,028
16,057
2,039
175,124
 
353
350
509
1,212
173,912
Total loans and advances at amortised cost
356,135
46,225
6,924
409,284
 
1,001
2,348
2,387
5,736
403,548
Off-balance sheet loan commitments and financial guarantee contracts2
368,634
26,320
1,175
396,129
 
225
307
22
554
395,575
Total3
724,769
72,545
8,099
805,413
 
1,226
2,655
2,409
6,290
799,123
 
 
 
 
 
 
 
 
 
 
 
 
As at 31.03.23
 
Three months ended 31.03.23
 
 
Coverage ratio
 
Loan impairment charge/(release) and loan loss rate
 
 
Stage 1
Stage 2
Stage 3
Total
 
Loan impairment charge/(release)
Loan loss rate
 
 
%
%
%
%
 
£m
bps
 
Barclays UK
0.2
2.9
19.9
0.8
 
 
147
 
31
 
Barclays International
1.2
26.9
57.4
6.9
 
 
368
 
384
 
Head Office
0.1
9.3
56.2
8.2
 
 
7
 
66
 
Total Barclays Group retail
0.3
6.6
38.4
1.9
 
 
522
 
90
 
Barclays UK
0.2
3.6
11.5
0.7
 
 
(41)
 
 
 
Barclays International
0.2
1.9
32.5
0.7
 
 
61
 
18
 
Head Office
100.0
7.0
 
 
 
 
 
Total Barclays Group wholesale1
0.2
2.2
25.0
0.7
 
 
20
 
5
 
Total loans and advances at amortised cost
0.3
5.1
34.5
1.4
 
 
542
 
54
 
Off-balance sheet loan commitments and financial guarantee contracts2
0.1
1.2
1.9
0.1
 
 
(16)
 
 
 
Other financial assets subject to impairment3
 
 
 
 
 
 
(2)
 
 
 
Total4
0.2
3.7
29.7
0.8
 
 
524
 
 
 
 
 
1
Includes Wealth UK and Private Banking exposures measured on an individual customer exposure basis and excludes Business Banking exposures, including lending under the government backed Bounce Back Loan Scheme (BBLS) of £6bn that are managed on a collective basis and reported within Barclays UK Retail. The net impact is a difference in total exposure of £3.4bn of balances reported as wholesale loans on page 24 in the Loans and advances at amortised cost by product disclosure.
2
Excludes loan commitments and financial guarantees of £12.4bn carried at fair value.
3
Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £197.8bn and impairment allowance of £151m. This comprises £10m ECL on £196.2bn Stage 1 assets, £8m on £1.4bn Stage 2 fair value through other comprehensive income assets, cash collateral and settlement balances and £133m on £146m Stage 3 other assets.
4
The annualised loan loss rate is 52bps after applying the total impairment charge of £524m.
 
 
 
Gross exposure
 
Impairment allowance
Net exposure
 
Stage 1
Stage 2
Stage 3
Total
 
Stage 1
Stage 2
Stage 3
Total
As at 31.12.22
£m
£m
£m
£m
 
£m
£m
£m
£m
£m
Barclays UK
160,424
24,837
2,711
187,972
 
232
718
485
1,435
186,537
Barclays International
33,735
4,399
1,793
39,927
 
392
1,200
949
2,541
37,386
Head Office
3,644
252
661
4,557
 
3
24
359
386
4,171
Total Barclays Group retail
197,803
29,488
5,165
232,456
 
627
1,942
1,793
4,362
228,094
Barclays UK
34,858
2,954
805
38,617
 
129
109
96
334
38,283
Barclays International
117,692
14,298
1,098
133,088
 
301
265
312
878
132,210
Head Office
192
18
210
 
18
18
192
Total Barclays Group wholesale1
152,742
17,252
1,921
171,915
 
430
374
426
1,230
170,685
Total loans and advances at amortised cost
350,545
46,740
7,086
404,371
 
1,057
2,316
2,219
5,592
398,779
Off-balance sheet loan commitments and financial guarantee contracts2
372,945
30,694
1,180
404,819
 
245
315
23
583
404,236
Total3
723,490
77,434
8,266
809,190
 
1,302
2,631
2,242
6,175
803,015
 
 
 
 
 
 
 
 
 
 
 
 
As at 31.12.22
 
Year ended 31.12.22
 
 
Coverage ratio
 
Loan impairment charge/(release) and loan loss rate
 
 
Stage 1
Stage 2
Stage 3
Total
 
Loan impairment charge/(release)
Loan loss rate
 
 
%
%
%
%
 
£m
bps
 
Barclays UK
0.1
2.9
17.9
0.8
 
 
169
 
9
 
Barclays International
1.2
27.3
52.9
6.4
 
 
763
 
191
 
Head Office
0.1
9.5
54.3
8.5
 
 
 
 
 
Total Barclays Group retail
0.3
6.6
34.7
1.9
 
 
932
 
40
 
Barclays UK
0.4
3.7
11.9
0.9
 
 
106
 
27
 
Barclays International
0.3
1.9
28.4
0.7
 
 
127
 
10
 
Head Office
100.0
8.6
 
 
 
 
 
Total Barclays Group wholesale1
0.3
2.2
22.2
0.7
 
 
233
 
14
 
Total loans and advances at amortised cost
0.3
5.0
31.3
1.4
 
 
1,165
 
29
 
Off-balance sheet loan commitments and financial guarantee contracts2
0.1
1.0
1.9
0.1
 
 
18
 
 
 
Other financial assets subject to impairment3
 
 
 
 
 
 
37
 
 
 
Total4
0.2
3.4
27.1
0.8
 
 
1,220
 
 
 
 
 
1
Includes Wealth UK and Private Banking exposures measured on an individual customer exposure basis and excludes Business Banking exposures, including lending under the government backed Bounce Back Loan Scheme (BBLS) of £6.6bn that are managed on a collective basis and reported within Barclays UK Retail. The net impact is a difference in total exposure of £3.8bn of balances reported as wholesale loans on page 24 in the Loans and advances at amortised cost by product disclosure.
2
Excludes loan commitments and financial guarantees of £14.9bn carried at fair value.
3
Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £180.1bn and impairment allowance of £163m. This comprises £10m ECL on £178.4bn Stage 1 assets, £9m on £1.5bn Stage 2 fair value through other comprehensive income assets, cash collateral and settlement balances and £144m on £149m Stage 3 other assets.
4
The annualised loan loss rate is 30bps after applying the total impairment charge of £1,220m.
  
 
Loans and advances at amortised cost by product
 
The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance with stage allocation by asset classification.
 
 
 
 
Stage 2
 
 
As at 31.03.23
Stage 1
Not past due
<=30 days past due
>30 days past due
Total
Stage 3
Total
Gross exposure
£m
£m
£m
£m
£m
£m
£m
Home loans
156,635
16,371
1,941
747
19,059
2,323
178,017
Credit cards, unsecured loans and other retail lending
42,655
7,227
377
439
8,043
2,012
52,710
Wholesale loans
156,845
18,840
157
126
19,123
2,589
178,557
Total
356,135
42,438
2,475
1,312
46,225
6,924
409,284
 
 
 
 
 
 
 
 
Impairment allowance
 
 
 
 
 
 
 
Home loans
33
53
13
9
75
412
520
Credit cards, unsecured loans and other retail lending
558
1,541
145
196
1,882
1,349
3,789
Wholesale loans
410
388
3
391
626
1,427
Total
1,001
1,982
161
205
2,348
2,387
5,736
 
 
 
 
 
 
 
 
Net exposure
 
 
 
 
 
 
 
Home loans
156,602
16,318
1,928
738
18,984
1,911
177,497
Credit cards, unsecured loans and other retail lending
42,097
5,686
232
243
6,161
663
48,921
Wholesale loans
156,435
18,452
154
126
18,732
1,963
177,130
Total
355,134
40,456
2,314
1,107
43,877
4,537
403,548
 
 
 
 
 
 
 
 
Coverage ratio
%
%
%
%
%
%
%
Home loans
0.3
0.7
1.2
0.4
17.7
0.3
Credit cards, unsecured loans and other retail lending
1.3
21.3
38.5
44.6
23.4
67.0
7.2
Wholesale loans
0.3
2.1
1.9
2.0
24.2
0.8
Total
0.3
4.7
6.5
15.6
5.1
34.5
1.4
 
 
 
 
 
 
 
 
As at 31.12.22
 
 
 
 
 
 
 
Gross exposure
£m
£m
£m
£m
£m
£m
£m
Home loans
153,672
15,990
1,684
526
18,200
2,414
174,286
Credit cards, unsecured loans and other retail lending
44,175
7,126
397
576
8,099
2,122
54,396
Wholesale loans
152,698
20,194
150
97
20,441
2,550
175,689
Total
350,545
43,310
2,231
1,199
46,740
7,086
404,371
 
 
 
 
 
 
 
 
Impairment allowance
 
 
 
 
 
 
 
Home loans
29
53
11
9
73
414
516
Credit cards, unsecured loans and other retail lending
582
1,483
129
220
1,832
1,278
3,692
Wholesale loans
446
403
6
2
411
527
1,384
Total
1,057
1,939
146
231
2,316
2,219
5,592
 
 
 
 
 
 
 
 
Net exposure
 
 
 
 
 
 
 
Home loans
153,643
15,937
1,673
517
18,127
2,000
173,770
Credit cards, unsecured loans and other retail lending
43,593
5,643
268
356
6,267
844
50,704
Wholesale loans
152,252
19,791
144
95
20,030
2,023
174,305
Total
349,488
41,371
2,085
968
44,424
4,867
398,779
 
 
 
 
 
 
 
 
Coverage ratio
%
%
%
%
%
%
%
Home loans
0.3
0.7
1.7
0.4
17.1
0.3
Credit cards, unsecured loans and other retail lending
1.3
20.8
32.5
38.2
22.6
60.2
6.8
Wholesale loans
0.3
2.0
4.0
2.1
2.0
20.7
0.8
Total
0.3
4.5
6.5
19.3
5.0
31.3
1.4
 
 
Measurement uncertainty
 
The Q123 ECL provision has been based on macroeconomic indicators used in the Q422 ECL scenario, rolled forward by one quarter, and updated to reflect changes in balances, risk parameters and individually assessed impaired names during the quarter. Management has applied economic uncertainty and other adjustments to modelled ECL outputs.
 
Key baseline macroeconomic indicators have been tracked against consensus updates to March 2023. Relative to Q422, these latest updates reflect slight improvements in certain key macroeconomic variables, along with deterioration in UK medium-term unemployment and HPI. When compared against the Q422 scenario, the current consensus remains materially in line. Hence these updates have not been reflected in the Q123 ECL modelled provision level.
 
In addition, coverage levels have been assessed in light of the potential impact of elevated levels of inflation on customer affordability and expert judgements updated accordingly with the resulting adjustments included within total post model adjustments of £0.3bn (31 December 2022: £0.3bn).
 
The following tables show the key macroeconomic variables used in the five scenarios (5 year annual paths) and the probability weights applied to each scenario.
 
 
 
Baseline average macroeconomic variables used in the calculation of ECL
 
2023
2024
2025
2026
2027
As at 31.03.23
%
%
%
%
%
UK GDP1
(0.6)
0.5
1.6
1.9
1.8
UK unemployment2
4.3
4.6
4.2
4.2
4.2
UK HPI3
(4.2)
(2.5)
1.7
2.2
2.2
UK bank rate
4.2
4.3
3.8
3.6
3.3
US GDP1
0.4
0.9
1.5
1.5
1.5
US unemployment4
4.1
4.7
4.7
4.7
4.7
US HPI5
1.5
1.5
2.1
2.4
2.4
US federal funds rate
4.7
3.9
3.2
3.0
3.0
 
2022
2023
2024
2025
2026
As at 31.12.22
%
%
%
%
%
UK GDP1
3.3
(0.8)
0.9
1.8
1.9
UK unemployment2
3.7
4.5
4.4
4.1
4.2
UK HPI3
8.4
(4.7)
(1.7)
2.2
2.2
UK bank rate
1.8
4.4
4.1
3.8
3.4
US GDP1
1.8
0.5
1.2
1.5
1.5
US unemployment4
3.7
4.3
4.7
4.7
4.7
US HPI5
11.2
1.8
1.5
2.3
2.4
US federal funds rate
2.1
4.8
3.6
3.1
3.0
 
 
1
Average Real GDP seasonally adjusted change in year.
2
Average UK unemployment rate 16-year+.
3
Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4
Average US civilian unemployment rate 16-year+.
5
Change in year end US HPI = FHFA House Price Index, relative to prior year end.
 
 
Downside 2 average economic variables used in the calculation of ECL
 
2023
2024
2025
2026
2027
As at 31.03.23
%
%
%
%
%
UK GDP1
(2.0)
(4.8)
1.0
2.4
1.9
UK unemployment2
5.0
8.2
8.1
7.5
6.9
UK HPI3
(13.6)
(19.6)
(13.9)
8.2
8.2
UK bank rate
6.1
8.0
6.9
5.8
4.5
US GDP1
(1.3)
(4.5)
1.0
2.8
1.8
US unemployment4
4.9
8.4
8.3
7.3
6.2
US HPI5
(2.1)
(3.9)
(4.1)
4.8
4.8
US federal funds rate
5.9
7.0
6.1
4.9
3.8
 
2022
2023
2024
2025
2026
As at 31.12.22
%
%
%
%
%
UK GDP1
3.3
(3.4)
(3.8)
2.0
2.3
UK unemployment2
3.7
6.0
8.4
8.0
7.4
UK HPI3
8.4
(18.3)
(18.8)
(7.7)
8.2
UK bank rate
1.8
7.3
7.9
6.6
5.5
US GDP1
1.8
(2.7)
(3.4)
2.0
2.6
US unemployment4
3.7
6.0
8.5
8.1
7.1
US HPI5
11.2
(3.1)
(4.0)
(1.9)
4.8
US federal funds rate
2.1
6.6
6.9
5.8
4.6
 
 
1
Average Real GDP seasonally adjusted change in year.
2
Average UK unemployment rate 16-year+.
3
Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4
Average US civilian unemployment rate 16-year+.
5
Change in year end US HPI = FHFA House Price Index, relative to prior year end.
 
 
Downside 1 average economic variables used in the calculation of ECL
 
2023
2024
2025
2026
2027
As at 31.03.23
%
%
%
%
%
UK GDP1
(1.3)
(2.2)
1.3
2.2
1.8
UK unemployment2
4.6
6.4
6.1
5.8
5.5
UK HPI3
(9.0)
(11.3)
(6.3)
5.2
5.2
UK bank rate
5.2
6.2
5.4
4.8
3.9
US GDP1
(0.4)
(1.8)
1.2
2.2
1.7
US unemployment4
4.5
6.5
6.5
6.0
5.4
US HPI5
(0.3)
(1.2)
(1.0)
3.6
3.6
US federal funds rate
5.4
5.6
4.6
4.0
3.4
 
2022
2023
2024
2025
2026
As at 31.12.22
%
%
%
%
%
UK GDP1
3.3
(2.1)
(1.5)
1.9
2.1
UK unemployment2
3.7
5.2
6.4
6.0
5.8
UK HPI3
8.4
(11.7)
(10.6)
(2.8)
5.2
UK bank rate
1.8
5.9
6.1
5.3
4.6
US GDP1
1.8
(1.1)
(1.1)
1.7
2.1
US unemployment4
3.7
5.1
6.6
6.4
5.9
US HPI5
11.2
(0.7)
(1.3)
0.2
3.6
US federal funds rate
2.1
5.8
5.4
4.4
3.9
 
 
1
Average Real GDP seasonally adjusted change in year.
2
Average UK unemployment rate 16-year+.
3
Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4
Average US civilian unemployment rate 16-year+.
5
Change in year end US HPI = FHFA House Price Index, relative to prior year end.
 
 
Upside 2 average economic variables used in the calculation of ECL
 
2023
2024
2025
2026
2027
As at 31.03.23
%
%
%
%
%
UK GDP1
1.7
4.1
3.1
2.5
2.3
UK unemployment2
3.6
3.4
3.4
3.4
3.4
UK HPI3
5.3
9.6
4.3
4.3
3.5
UK bank rate
3.3
2.8
2.5
2.5
2.5
US GDP1
2.3
3.8
2.9
2.8
2.8
US unemployment4
3.4
3.3
3.3
3.3
3.3
US HPI5
4.6
5.3
4.5
4.5
4.5
US federal funds rate
3.8
3.1
2.8
2.8
2.8
 
2022
2023
2024
2025
2026
As at 31.12.22
%
%
%
%
%
UK GDP1
3.3
2.8
3.7
2.9
2.4
UK unemployment2
3.7
3.5
3.4
3.4
3.4
UK HPI3
8.4
8.7
7.5
4.4
4.2
UK bank rate
1.8
3.1
2.6
2.5
2.5
US GDP1
1.8
3.3
3.5
2.8
2.8
US unemployment4
3.7
3.3
3.3
3.3
3.3
US HPI5
11.2
5.8
5.1
4.5
4.5
US federal funds rate
2.1
3.6
2.9
2.8
2.8
 
 
1
Average Real GDP seasonally adjusted change in year.
2
Average UK unemployment rate 16-year+.
3
Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4
Average US civilian unemployment rate 16-year+.
5
Change in year end US HPI = FHFA House Price Index, relative to prior year end.
 
 
Upside 1 average economic variables used in the calculation of ECL
 
2023
2024
2025
2026
2027
As at 31.03.23
%
%
%
%
%
UK GDP1
0.5
2.2
2.3
2.2
2.1
UK unemployment2
3.9
4.0
3.8
3.8
3.8
UK HPI3
0.5
3.4
3.0
3.3
2.8
UK bank rate
3.5
3.3
3.1
2.8
2.8
US GDP1
1.4
2.4
2.2
2.2
2.2
US unemployment4
3.7
4.0
4.0
4.0
4.0
US HPI5
3.0
3.4
3.3
3.4
3.4
US federal funds rate
4.1
3.6
3.0
3.0
3.0
 
2022
2023
2024
2025
2026
As at 31.12.22
%
%
%
%
%
UK GDP1
3.3
1.0
2.3
2.4
2.1
UK unemployment2
3.7
4.0
3.9
3.8
3.8
UK HPI3
8.4
1.8
2.9
3.3
3.2
UK bank rate
1.8
3.5
3.3
3.0
2.8
US GDP1
1.8
1.9
2.3
2.2
2.2
US unemployment4
3.7
3.8
4.0
4.0
4.0
US HPI5
11.2
3.8
3.3
3.4
3.4
US federal funds rate
2.1
3.9
3.4
3.0
3.0
 
 
1
Average Real GDP seasonally adjusted change in year.
2
Average UK unemployment rate 16-year+.
3
Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4
Average US civilian unemployment rate 16-year+.
5
Change in year end US HPI = FHFA House Price Index, relative to prior year end.
 
 
Scenario probability weighting
 
Upside 2
Upside 1
Baseline
Downside 1
Downside 2
 
%
%
%
%
%
As at 31.03.23
 
 
 
 
 
Scenario probability weighting
10.9
23.1
39.4
17.6
9.0
As at 31.12.22
 
 
 
 
 
Scenario probability weighting
10.9
23.1
39.4
17.6
9.0
 
Treasury and Capital Risk
 
Regulatory minimum requirements
 
Capital
 
The Group’s Overall Capital Requirement for CET1 is 11.4% comprising a 4.5% Pillar 1 minimum, a 2.5% Capital Conservation Buffer (CCB), a 1.5% Global Systemically Important Institution (G-SII) buffer, a 2.4% Pillar 2A requirement and a 0.5% Countercyclical Capital Buffer (CCyB).
 
The Group’s CCyB is based on the buffer rate applicable for each jurisdiction in which the Group has exposures. On 13 December 2021, the Financial Policy Committee (FPC) announced the re-introduction of a CCyB rate of 1% for UK exposures with effect from 13 December 2022. The buffer rates set by other national authorities for non-UK exposures are not currently material. Overall, this results in a 0.5% CCyB for the Group. On 5 July 2022, the FPC announced that the UK CCyB rate will be increased from 1% to 2% with effect from 5 July 2023.
 
The Group’s Pillar 2A requirement as per the PRA’s Individual Capital Requirement is 4.3% of which at least 56.25% needs to be met with CET1 capital, equating to 2.4% of RWAs. The Pillar 2A requirement, based on a point in time assessment, has been set as a proportion of RWAs and is subject to at least annual review.
 
The Group’s CET1 target ratio of 13-14% takes into account headroom above requirements which includes a confidential institution-specific PRA buffer. The Group remains above its minimum capital regulatory requirements including the PRA buffer.
 
 
Leverage
 
The Group is subject to a UK leverage ratio requirement of 4.0%. This comprises the 3.25% minimum requirement, a G-SII additional leverage ratio buffer (G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer (CCLB) of 0.2%. Although the leverage ratio is expressed in terms of Tier 1 (T1) capital, 75% of the minimum requirement, equating to 2.4%, needs to be met with CET1 capital. In addition, the G-SII ALRB and CCLB must be covered solely with CET1 capital. The CET1 capital held against the 0.53% G-SII ALRB was £6.1bn and against the 0.2% CCLB was £2.3bn.
 
The Group is also required to disclose an average UK leverage ratio which is based on capital on the last day of each month in the quarter and an exposure measure for each day in the quarter.
 
 
MREL
 
The Group is required to meet the higher of: (i) two times the sum of 8% Pillar 1 and 4.3% Pillar 2A equating to 24.5% of RWAs; and (ii) 6.75% of leverage exposures. In addition, the higher of regulatory capital and leverage buffers apply. CET1 capital cannot be counted towards both MREL and the buffers, meaning that the buffers, including the above mentioned confidential institution-specific PRA buffer, will effectively be applied above MREL requirements.
 
In the disclosures that follow, references to CRR, as amended by CRR II, mean the capital regulatory requirements, as they form part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended.
 
 
 
Capital ratios1,2
As at 31.03.23
As at 31.12.22
CET1
13.6%
13.9%
T1
17.6%
17.9%
Total regulatory capital
20.2%
20.8%
 
 
 
Capital resources
£m
£m
Total equity excluding non-controlling interests per the balance sheet
69,699
68,292
Less: other equity instruments (recognised as AT1 capital)
(13,784)
(13,284)
Adjustment to retained earnings for foreseeable ordinary share dividends
(338)
(787)
Adjustment to retained earnings for foreseeable repurchase of shares
(224)
Adjustment to retained earnings for foreseeable other equity coupons
(52)
(37)
 
 
 
Other regulatory adjustments and deductions
 
 
Additional value adjustments (PVA)
(1,913)
(1,726)
Goodwill and intangible assets
(8,642)
(8,224)
Deferred tax assets that rely on future profitability excluding temporary differences
(1,435)
(1,500)
Fair value reserves related to gains or losses on cash flow hedges
6,164
7,237
Excess of expected losses over impairment
(232)
(119)
Gains or losses on liabilities at fair value resulting from own credit
(86)
(620)
Defined benefit pension fund assets
(3,593)
(3,430)
Direct and indirect holdings by an institution of own CET1 instruments
(20)
(20)
Adjustment under IFRS 9 transitional arrangements
245
700
Other regulatory adjustments
196
396
CET1 capital
45,985
46,878
 
 
 
AT1 capital
 
 
Capital instruments and related share premium accounts
13,784
13,284
Other regulatory adjustments and deductions
(60)
(60)
AT1 capital
13,724
13,224
 
 
 
T1 capital
59,709
60,102
 
 
 
T2 capital
 
 
Capital instruments and related share premium accounts
7,538
9,000
Qualifying T2 capital (including minority interests) issued by subsidiaries
1,061
1,095
Credit risk adjustments (excess of impairment over expected losses)
66
35
Other regulatory adjustments and deductions
(160)
(160)
Total regulatory capital
68,214
70,072
 
 
 
Total RWAs
338,448
336,518
 
 
1
CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9 transitional arrangements and the grandfathering of CRR II non-compliant capital instruments.
2
The fully loaded CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays PLC AT1 securities, was 13.5%, with £45.7bn of CET1 capital and £338.4bn of RWAs calculated without applying the transitional arrangements of the CRR as amended by CRR II.
 
 
Movement in CET1 capital
Three months ended 31.03.23
 
£m
Opening CET1 capital
46,878
 
 
Profit for the period attributable to equity holders
2,029
Own credit relating to derivative liabilities
(6)
Ordinary share dividends paid and foreseen
(344)
Purchased and foreseeable share repurchase
(500)
Other equity coupons paid and foreseen
(261)
Increase in retained regulatory capital generated from earnings
918
 
 
Net impact of share schemes
(290)
Fair value through other comprehensive income reserve
149
Currency translation reserve
(531)
Other reserves
2
Decrease in other qualifying reserves
(670)
 
 
Pension remeasurements within reserves
135
Defined benefit pension fund asset deduction
(163)
Net impact of pensions
(28)
 
 
Additional value adjustments (PVA)
(187)
Goodwill and intangible assets
(418)
Deferred tax assets that rely on future profitability excluding those arising from temporary differences
65
Excess of expected loss over impairment
(113)
Adjustment under IFRS 9 transitional arrangements
(455)
Other regulatory adjustments
(5)
Decrease in regulatory capital due to adjustments and deductions
(1,113)
 
 
Closing CET1 capital
45,985
 
 
CET1 capital decreased £0.9bn to £46.0bn (December 2022: £46.9bn).
£2.0bn of capital generated from profit was partially offset by distributions of £1.1bn comprising:
£0.5bn of buybacks announced with FY22 results
£0.3bn accrual towards a FY23 dividend
£0.3bn of equity coupons paid and foreseen
Other significant movements in the period were:
£0.5bn decrease in the currency translation reserve driven by the depreciation of period end USD against GBP
£0.4bn increase in the goodwill and intangibles deduction primarily as a result of the acquisition of KMC
£0.5bn decrease in IFRS 9 transitional relief primarily due to the relief applied to the pre-2020 impairment charge reducing to 0% in 2023 from 25% in 2022 and the relief applied to the post-2022 impairment charge reducing to 50% in 2023 from 75% in 2022.
 
 
RWAs by risk type and business
 
Credit risk
 
Counterparty credit risk
 
Market Risk
 
Operational risk
Total RWAs
 
STD
IRB
 
STD
IRB
Settlement Risk
CVA
 
STD
IMA
 
 
 
As at 31.03.23
£m
£m
 
£m
£m
£m
£m
 
£m
£m
 
£m
£m
Barclays UK
7,816
55,174
 
246
115
 
196
 
11,054
74,601
Corporate and Investment Bank
33,904
75,225
 
17,014
21,692
237
2,811
 
15,734
23,136
 
27,093
216,846
Consumer, Cards and Payments
26,511
4,343
 
205
45
60
 
525
 
6,527
38,216
Barclays International
60,415
79,568
 
17,219
21,737
237
2,871
 
15,734
23,661
 
33,620
255,062
Head Office
2,578
7,016
 
 
 
(809)
8,785
Barclays Group
70,809
141,758
 
17,465
21,737
237
2,986
 
15,930
23,661
 
43,865
338,448
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As at 31.12.22
 
 
 
 
 
 
 
 
 
 
 
 
 
Barclays UK
6,836
54,752
 
167
72
 
233
 
11,023
73,083
Corporate and Investment Bank
35,738
75,413
 
16,814
21,449
80
3,093
 
13,716
22,497
 
27,064
215,864
Consumer, Cards and Payments
27,882
3,773
 
214
46
61
 
388
 
6,559
38,923
Barclays International
63,620
79,186
 
17,028
21,495
80
3,154
 
13,716
22,885
 
33,623
254,787
Head Office
2,636
6,843
 
 
 
(831)
8,648
Barclays Group
73,092
140,781
 
17,195
21,495
80
3,226
 
13,949
22,885
 
43,815
336,518
 
 
Movement analysis of RWAs
Credit risk
Counterparty credit risk
Market risk
Operational risk
Total RWAs
 
£m
£m
£m
£m
£m
Opening RWAs (as at 31.12.22)
213,873
41,996
36,834
43,815
336,518
Book size
(1,091)
1,189
3,051
50
3,199
Acquisitions and disposals
688
688
Book quality
1,039
134
1,173
Model updates
Methodology and policy
640
267
907
Foreign exchange movements1
(2,582)
(1,161)
(294)
(4,037)
Total RWA movements
(1,306)
429
2,757
50
1,930
Closing RWAs (as at 31.03.23)
212,567
42,425
39,591
43,865
338,448
 
 
1
Foreign exchange movements does not include the impact of foreign exchange for modelled market risk or operational risk.
 
 
Overall RWAs increased £1.9bn to £338.4bn (December 2022: £336.5bn)
Credit risk RWAs decreased £1.3bn:
A £1.1bn decrease in book size primarily driven by business activities within CIB
A £1.0bn increase in book quality RWAs driven by an increase in mortgages due to HPI refresh and a deterioration in credit quality within CIB
A £2.6bn decrease in FX primarily due to the depreciation of period end USD against GBP
Counterparty Credit risk RWAs increased £0.4bn:
A £1.2bn increase in book size primarily due to an increase in SFT client and trading activity within Global Markets
A £1.2bn decrease in FX primarily due to the depreciation of period end USD against GBP
Market risk RWAs increased £2.8bn:
A £3.1bn increase in book size primarily due to increased client and trading activity within Global Markets
 
 
Leverage ratios1,2
As at 31.03.23
As at 31.12.22
£m
£m
Average UK leverage ratio
4.8%
4.8%
Average T1 capital
59,488
60,865
Average UK leverage exposure
1,251,286
1,280,972
 
 
 
UK leverage ratio
5.1%
5.3%
 
 
 
CET1 capital
45,985
46,878
AT1 capital
13,724
13,224
T1 capital
59,709
60,102
 
 
 
UK leverage exposure
1,168,899
1,129,973
 
 
 
UK leverage exposure
 
 
Accounting assets
 
 
Derivative financial instruments
257,439
302,380
Derivative cash collateral
64,899
69,048
Securities financing transactions (SFT)
229,182
189,637
Loans and advances and other assets
987,530
952,634
Total IFRS assets
1,539,050
1,513,699
 
 
 
Regulatory consolidation adjustments
(6,998)
(8,278)
 
 
 
Derivatives adjustments
 
 
Derivatives netting
(217,312)
(256,309)
Adjustments to collateral
(50,131)
(52,715)
Net written credit protection
18,354
16,190
Potential future exposure (PFE) on derivatives
85,893
84,168
Total derivatives adjustments
(163,196)
(208,666)
 
 
 
SFT adjustments
25,787
24,203
 
 
 
Regulatory deductions and other adjustments
(21,984)
(21,447)
 
 
 
Weighted off-balance sheet commitments
120,754
124,169
 
 
 
Qualifying central bank claims
(280,346)
(272,321)
 
 
 
Settlement netting
(44,168)
(21,386)
 
 
 
UK leverage exposure
1,168,899
1,129,973
 
 
1
Capital and leverage measures are calculated applying the transitional arrangements of the CRR as amended by CRR II.
2
Fully loaded average UK leverage ratio was 4.7%, with £59.2bn of T1 capital and £1,251.0bn of leverage exposure. Fully loaded UK leverage ratio was 5.1%, with £59.5bn of T1 capital and £1,168.7bn of leverage exposure. Fully loaded UK leverage ratios are calculated without applying the transitional arrangements of the CRR as amended by CRR II.
 
 
The UK leverage ratio decreased to 5.1% (December 2022: 5.3%) primarily due to a £38.9bn increase in the leverage exposure and a £0.4bn decrease in Tier 1 capital. The UK leverage exposure increased to £1,168.9bn (December 2022: £1,130.0bn) largely due to an increase in SFT client and trading activity within Global Markets.
 
The average UK leverage ratio remained at 4.8% (December 2022: 4.8%) primarily due to a decrease in the average T1 capital offset by a decrease in the average leverage exposure of £29.7bn to £1,251.3bn, largely due to a reduction in derivatives as well as lower daily average SFT activity in the quarter, compared to Q4 2022.
 
 
 
MREL
 
 
 
 
 
MREL requirements including buffers1,2
Total requirement (£m) based on
 
Requirement as a percentage of:
 
As at 31.03.23
As at 31.12.22
 
As at 31.03.23
As at 31.12.22
Requirement based on RWAs (minimum requirement)
98,167
97,387
 
29.0%
28.9%
Requirement based on UK leverage exposure
94,012
91,213
 
8.0%
8.1%
 
 
 
 
 
 
 
 
 
 
 
 
Own funds and eligible liabilities2
 
 
 
As at 31.03.23
As at 31.12.22
 
 
 
 
£m
£m
CET1 capital
 
 
 
45,985
46,878
AT1 capital instruments and related share premium accounts3
 
 
 
13,724
13,224
T2 capital instruments and related share premium accounts3
 
 
 
7,444
8,875
Eligible liabilities
 
 
 
43,489
43,851
Total Barclays PLC (the Parent company) own funds and eligible liabilities
 
110,642
112,828
 
 
 
 
 
 
Total RWAs
 
 
 
338,448
336,518
Total UK leverage exposure
 
 
 
1,168,899
1,129,973
 
 
 
 
 
 
Own funds and eligible liabilities ratios as a percentage of:
 
 
 
As at 31.03.23
As at 31.12.22
Total RWAs
 
 
 
32.7%
33.5%
Total UK leverage exposure
 
 
 
9.5%
10.0%
 
 
As at 31 March 2023, Barclays PLC (the Parent company) held £110.6bn of own funds and eligible liabilities equating to 32.7% of RWAs. This was in excess of the Group's MREL requirement, excluding the PRA buffer, to hold £98.2bn of own funds and eligible liabilities equating to 29% of RWAs. The Group remains above its MREL regulatory requirement including the PRA buffer.
 
 
1
Minimum requirement excludes the confidential institution-specific PRA buffer.
2
CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9 transitional arrangements and the grandfathering of CRR II non-compliant capital instruments.
3
Includes other AT1 capital regulatory adjustments and deductions of £60m (December 2022: £60m), and other T2 credit risk adjustments and deductions of £94m (December 2022: £125m).
 
 
Condensed Consolidated Financial Statements
 
 
Condensed consolidated income statement (unaudited)
 
Three months ended 31.03.23
Three months ended 31.03.22
 
£m
£m
Total income
7,237
6,496
Operating expenses excluding litigation and conduct
(4,111)
(3,588)
Litigation and conduct
1
(523)
Operating expenses
(4,110)
(4,111)
Other net expenses
(5)
(10)
Profit before impairment
3,122
2,375
Credit impairment charges
(524)
(141)
Profit before tax
2,598
2,234
Tax charge
(561)
(614)
Profit after tax
2,037
1,620
 
 
 
Attributable to:
 
 
Equity holders of the parent
1,783
1,404
Other equity instrument holders
246
215
Total equity holders of the parent
2,029
1,619
Non-controlling interests
8
1
Profit after tax
2,037
1,620
 
 
 
Earnings per share
p
p
Basic earnings per ordinary share
11.3
8.4
 
 
Condensed consolidated balance sheet (unaudited)
 
As at 31.03.23
As at 31.12.22
Assets
£m
£m
Cash and balances at central banks
265,874
256,351
Cash collateral and settlement balances
129,622
112,597
Loans and advances at amortised cost
403,548
398,779
Reverse repurchase agreements and other similar secured lending
771
776
Trading portfolio assets
137,857
133,813
Financial assets at fair value through the income statement
247,965
213,568
Derivative financial instruments
257,439
302,380
Financial assets at fair value through other comprehensive income
66,361
65,062
Investments in associates and joint ventures
912
922
Goodwill and intangible assets
8,664
8,239
Current tax assets
310
385
Deferred tax assets
6,489
6,991
Other assets
13,238
13,836
Total assets
1,539,050
1,513,699
 
 
 
Liabilities
 
 
Deposits at amortised cost
555,724
545,782
Cash collateral and settlement balances
117,234
96,927
Repurchase agreements and other similar secured borrowing
28,386
27,052
Debt securities in issue
116,647
112,881
Subordinated Liabilities
10,072
11,423
Trading portfolio liabilities
90,079
72,924
Financial liabilities designated at fair value
289,428
271,637
Derivative financial instruments
247,167
289,620
Current tax liabilities
562
580
Deferred tax liabilities
17
16
Other liabilities
13,079
15,597
Total liabilities
1,468,395
1,444,439
 
 
 
Equity
 
 
Called up share capital and share premium
4,344
4,373
Other reserves
(1,993)
(2,192)
Retained earnings
53,564
52,827
Shareholders' equity attributable to ordinary shareholders of the parent
55,915
55,008
Other equity instruments
13,784
13,284
Total equity excluding non-controlling interests
69,699
68,292
Non-controlling interests
956
968
Total equity
70,655
69,260
 
 
 
Total liabilities and equity
1,539,050
1,513,699
 
 
Condensed consolidated statement of changes in equity (unaudited)
 
Called up share capital and share premium
Other equity instruments
Other reserves
Retained earnings
Total
Non-controlling interests
Total equity
Three months ended 31.03.2023
£m
£m
£m
£m
£m
£m
£m
Balance as at 1 January 2023
4,373
13,284
(2,192)
52,827
68,292
968
69,260
Profit after tax
246
1,783
2,029
8
2,037
Retirement benefit remeasurements
135
135
135
Other comprehensive profit after tax for the year
151
151
151
Total comprehensive income for the period
246
151
1,918
2,315
8
2,323
Employee share schemes and hedging thereof
16
356
372
372
Issue and redemption of other equity instruments
500
(5)
495
495
Other equity instruments coupon paid
(246)
(246)
(246)
Vesting of employee share schemes
3
(470)
(467)
(467)
Dividends paid
(793)
(793)
(8)
(801)
Repurchase of shares
(45)
45
(276)
(276)
(276)
Other movements
7
7
(12)
(5)
Balance as at 31 March 2023
4,344
13,784
(1,993)
53,564
69,699
956
70,655
 
 
Other reserves
As at 31.03.23
As at 31.12.22
 
£m
£m
Currency translation reserve
4,241
4,772
Fair value through other comprehensive income reserve
(1,411)
(1,560)
Cash flow hedging reserve
(6,162)
(7,235)
Own credit reserve
(73)
467
Other reserves and treasury shares
1,412
1,364
Total
(1,993)
(2,192)
 
 
The Group’s management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by management.
 
However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well.
 
Appendix: Non-IFRS Performance Measures
 
 
Non-IFRS performance measures glossary
 
 
 
Measure
Definition
Loan: deposit ratio
Loans and advances at amortised cost divided by deposits at amortised cost.
Period end allocated tangible equity
Allocated tangible equity is calculated as 13.5% (2022: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Group’s tangible shareholders’ equity and the amounts allocated to businesses.
Average tangible shareholders’ equity
Calculated as the average of the previous month’s period end tangible equity and the current month’s period end tangible equity. The average tangible shareholders’ equity for the period is the average of the monthly averages within that period.
Average allocated tangible equity
Calculated as the average of the previous month’s period end allocated tangible equity and the current month’s period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period.
Return on average tangible shareholders’ equity
Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of average shareholders’ equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets and goodwill. The components of the calculation have been included on pages 39 to 40.
Return on average allocated tangible equity
Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of average allocated tangible equity. The components of the calculation have been included on pages 39 to 41.
Operating expenses excluding litigation and conduct
A measure of total operating expenses excluding litigation and conduct charges.
Operating costs
A measure of total operating expenses excluding litigation and conduct charges and UK bank levy.
Cost: income ratio
Total operating expenses divided by total income.
Loan loss rate
Quoted in basis points and represents total impairment charges divided by gross loans and advances held at amortised cost at the balance sheet date. The components of the calculation have been included on page 22.
Net interest margin
Annualised net interest income divided by the sum of average customer assets. The components of the calculation have been included on page 21.
Tangible net asset value per share
Calculated by dividing shareholders’ equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The components of the calculation have been included on page 42.
Profit before impairment
Calculated by excluding credit impairment charges or releases from profit before tax.
 
 
Returns
 
Return on average tangible equity is calculated as profit after tax attributable to ordinary equity holders of the parent as a proportion of average tangible equity, excluding non-controlling and other equity interests for businesses. Allocated tangible equity has been calculated as 13.5% (2022: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office average allocated tangible equity represents the difference between the Group’s average tangible shareholders’ equity and the amounts allocated to businesses.
 
 
 
 
Profit/(loss) attributable to ordinary equity holders of the parent
 
Average tangible equity
 
Return on average tangible equity
For the three months ended 31.03.23
£m
 
£bn
 
%
Barclays UK
515
 
10.3
 
20.0
    Corporate and Investment Bank
1,209
 
31.8
 
15.2
    Consumer, Cards and Payments
139
 
5.3
 
10.5
Barclays International
1,348
 
37.1
 
14.5
Head Office
(80)
 
0.2
 
n/m
Barclays Group
1,783
 
47.6
 
15.0
 
 
 
 
 
 
For the three months ended 31.03.22
 
 
 
 
 
Barclays UK
396
 
10.1
 
15.6
    Corporate and Investment Bank
1,316
 
30.8
 
17.1
    Consumer, Cards and Payments
(16)
 
4.3
 
(1.5)
Barclays International
1,300
 
35.1
 
14.8
Head Office
(292)
 
3.6
 
n/m
Barclays Group
1,404
 
48.8
 
11.5
 
 
Barclays Group
 
 
 
 
 
 
 
 
 
 
Return on average tangible shareholders' equity
Q123
 
Q422
Q322
Q222
Q122
 
Q4211
Q3211
Q2211
£m
 
£m
£m
£m
£m
 
£m
£m
£m
Attributable profit
1,783
 
1,036
1,512
1,071
1,404
 
1,079
1,374
2,048
 
 
 
 
 
 
 
 
 
 
 
 
£bn
 
£bn
£bn
£bn
£bn
 
£bn
£bn
£bn
Average shareholders' equity
55.9
 
54.9
56.8
57.1
56.9
 
56.1
56.5
54.4
Average goodwill and intangibles
(8.3)
 
(8.2)
(8.2)
(8.1)
(8.1)
 
(8.1)
(8.2)
(7.9)
Average tangible shareholders' equity
47.6
 
46.7
48.6
49.0
48.8
 
48.0
48.3
46.5
 
 
 
 
 
 
 
 
 
 
 
Return on average tangible shareholders' equity
15.0%
 
8.9%
12.5%
8.7%
11.5%
 
9.0%
11.4%
17.6%
 
 
 
 
 
 
 
 
 
 
 
 
 
Barclays UK
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
Q123
 
Q422
Q322
Q222
Q122
 
Q421
Q321
Q221
£m
 
£m
£m
£m
£m
 
£m
£m
£m
Attributable profit
515
 
474
549
458
396
 
420
317
721
 
 
 
 
 
 
 
 
 
 
 
 
£bn
 
£bn
£bn
£bn
£bn
 
£bn
£bn
£bn
Average allocated equity
13.9
 
13.7
13.5
13.6
13.7
 
13.6
13.6
13.5
Average goodwill and intangibles
(3.6)
 
(3.5)
(3.6)
(3.6)
(3.6)
 
(3.6)
(3.6)
(3.6)
Average allocated tangible equity
10.3
 
10.2
9.9
10.0
10.1
 
10.0
10.0
9.9
 
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
20.0%
 
18.7%
22.1%
18.4%
15.6%
 
16.8%
12.7%
29.1%
 
 
1
The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities.
 
 
Barclays International
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
Q123
 
Q422
Q322
Q222
Q122
 
Q4211
Q3211
Q2211
£m
 
£m
£m
£m
£m
 
£m
£m
£m
Attributable profit
1,348
 
625
1,136
783
1,300
 
818
1,191
1,207
 
 
 
 
 
 
 
 
 
 
 
 
£bn
 
£bn
£bn
£bn
£bn
 
£bn
£bn
£bn
Average allocated equity
38.1
 
39.9
40.1
38.2
36.0
 
33.8
32.7
33.0
Average goodwill and intangibles
(1.0)
 
(1.0)
(1.0)
(0.9)
(0.9)
 
(0.9)
(0.9)
(0.6)
Average allocated tangible equity
37.1
 
38.9
39.1
37.3
35.1
 
32.9
31.8
32.4
 
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
14.5%
 
6.4%
11.6%
8.4%
14.8%
 
9.9%
14.9%
14.9%
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate and Investment Bank
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
Q123
 
Q422
Q322
Q222
Q122
 
Q4211
Q3211
Q2211
£m
 
£m
£m
£m
£m
 
£m
£m
£m
Attributable profit
1,209
 
454
1,015
579
1,316
 
695
1,085
989
 
 
 
 
 
 
 
 
 
 
 
 
£bn
 
£bn
£bn
£bn
£bn
 
£bn
£bn
£bn
Average allocated equity
31.8
 
33.7
34.0
32.7
30.8
 
28.7
27.8
28.4
Average goodwill and intangibles
 
 
Average allocated tangible equity
31.8
 
33.7
34.0
32.7
30.8
 
28.7
27.8
28.4
 
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
15.2%
 
5.4%
11.9%
7.1%
17.1%
 
9.7%
15.6%
14.0%
 
 
Consumer, Cards and Payments
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
Q123
 
Q422
Q322
Q222
Q122
 
Q421
Q321
Q221
£m
 
£m
£m
£m
£m
 
£m
£m
£m
Attributable profit/(loss)
139
 
171
121
204
(16)
 
123
106
218
 
 
 
 
 
 
 
 
 
 
 
 
£bn
 
£bn
£bn
£bn
£bn
 
£bn
£bn
£bn
Average allocated equity
6.3
 
6.2
6.1
5.5
5.2
 
5.1
4.9
4.6
Average goodwill and intangibles
(1.0)
 
(1.0)
(1.0)
(0.9)
(0.9)
 
(0.9)
(0.9)
(0.6)
Average allocated tangible equity
5.3
 
5.2
5.1
4.6
4.3
 
4.2
4.0
4.0
 
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
10.5%
 
13.0%
9.5%
17.8%
(1.5)%
 
11.7%
10.5%
21.8%
 
 
1
The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities.
 
 
Tangible net asset value per share
As at 31.03.23
As at 31.12.22
As at 31.03.22
 
£m
£m
£m
Total equity excluding non-controlling interests
69,699
68,292
68,465
Other equity instruments
(13,784)
(13,284)
(11,119)
Goodwill and intangibles
(8,664)
(8,239)
(8,046)
Tangible shareholders' equity attributable to ordinary shareholders of the parent
47,251
46,769
49,300
 
 
 
 
 
m
m
m
Shares in issue
15,701
15,871
16,762
 
 
 
 
 
p
p
p
Tangible net asset value per share
301
295
294
 
 
Notable Items
 
 
 
 
Three months ended 31.03.23
Three months ended 31.03.22
£m
Profit before tax
Attributable profit
Profit before tax
Attributable profit
Statutory
2,598
1,783
2,234
1,404
Net impact from the Over-issuance of Securities
(320)
(240)
Customer remediation costs on legacy loan portfolio
(181)
(147)
Other litigation and conduct
1
2
(22)
(15)
Re-measurement of UK DTAs
(346)
Excluding the impact of notable items
2,597
1,781
2,757
2,152
 
 
The Group’s management believes that the non-IFRS performance measures excluding notable items, included in the table above, provide valuable information to enable users of the financial statements to assess the performance of the Group. The notable items are separately identified within the Group’s results disclosures which, when excluded from Barclays’ statutory financials, provide an underlying profit and loss performance of the Group and enables consistent comparison of performance from one period to another.
 
These non-IFRS performance measures excluding notable items are included as a reference point only and are not incorporated within any of the key financial metrics used in our Group Targets, which are measured on a statutory basis.
 
Shareholder Information
 
 
 
 
 
 
 
 
 
Results timetable1
 
 
Date
 
 
 
2023 Interim Results Announcement
 
 
27 July 2023
 
 
 
 
 
 
 
 
 
 
 
 
% Change3
Exchange rates2
31.03.23
31.12.22
31.03.22
 
31.12.22
31.03.22
Period end - USD/GBP
1.23
1.21
1.31
 
2%
(6)%
3 month average - USD/GBP
1.22
1.17
1.34
 
4%
(9)%
Period end - EUR/GBP
1.14
1.13
1.19
 
1%
(4)%
3 month average - EUR/GBP
1.13
1.15
1.20
 
(2)%
(6)%
 
 
 
 
 
 
 
Share price data
 
 
 
 
 
 
Barclays PLC (p)
145.80
158.52
148.30
 
 
 
Barclays PLC number of shares (m)4
15,701
15,871
16,762
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For further information please contact
 
 
 
 
 
 
 
 
 
 
 
 
 
Investor relations
Media relations
Adam Strachan +1 212 526 8442
Tom Hoskin +44 (0) 20 7116 4755
James Johnson +44 (0) 20 7116 7233
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
More information on Barclays can be found on our website: home.barclays
 
 
 
 
 
 
 
 
 
 
 
Registered office
 
 
 
 
 
 
1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839.
 
 
 
 
 
 
 
 
Registrar
 
 
 
 
 
 
Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom.
 
Tel: 0371 384 20555 from the UK or +44 121 415 7004 from overseas.
 
 
 
 
 
 
 
 
American Depositary Receipts (ADRs)
 
 
 
 
 
 
EQ Shareowner Services
P.O. Box 64504
St. Paul, MN 55164-0504
United States of America
shareowneronline.com
 
 
 
 
 
Toll Free Number: +1 800-990-1135
 
 
 
 
 
 
Outside the US +1 651-453-2128
 
 
 
 
 
 
 
 
 
 
 
 
 
Delivery of ADR certificates and overnight mail
 
 
 
 
 
 
EQ Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100, USA.
 
 
1
Note that these dates are provisional and subject to change.
2
The average rates shown above are derived from daily spot rates during the year.
3
The change is the impact to GBP reported information.
4
The number of shares of 15,701m as at 31 March is different from the 15,688m quoted in the 3 April 2023 announcement because the share buyback transactions executed on 30 and 31 March 2023 did not settle until 3 April 2023 and 4 April 2023 respectively.
5
Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales.